<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.pharmaceutical-business-review.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-dea-reschedules-gw-pharmaceuticals-epidiolex-to-schedule-v/attachment/epilepsy-generic/</loc>
		<lastmod>2018-09-28T09:37:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/zenatek-tracking/attachment/remote-monitoring-5l/</loc>
		<lastmod>2018-09-28T09:42:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/zenatek-tracking/whitepapers/global-supply-chain-security/attachment/f73dfb6d-0647-4977-955f-c1ede816922a/</loc>
		<lastmod>2018-09-28T10:01:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/a-beginners-guide-to-quality-risk-management/attachment/nsf-pb-white-paper-aging-facilities/</loc>
		<lastmod>2018-09-28T10:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regeneron-skin-cancer-libtayo/attachment/skincancer/</loc>
		<lastmod>2018-10-01T07:35:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ksq-therapeutics-secures-80m-funds-to-advance-development-of-oncology-drug-candidates/attachment/onco/</loc>
		<lastmod>2018-10-01T09:21:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inotrems-nangibotide-yields-positive-results-in-septic-shock-phase-iia-study/attachment/inotrem-comunnique-inotrem/</loc>
		<lastmod>2018-10-01T11:07:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shield-therapeutics-nda-feraccru/attachment/tablets-strips-generic/</loc>
		<lastmod>2018-10-01T12:03:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/recipharm-acquires-sanofi-inhalation-contract-manufacturing-business/attachment/handshake/</loc>
		<lastmod>2018-10-01T15:30:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr-reddys-laboratories-sells-antibiotic-manufacturing-site-in-bristol-tennessee/attachment/medicine/</loc>
		<lastmod>2018-10-01T16:36:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shield-therapeutics-nda-feraccru/attachment/thought-catalog/</loc>
		<lastmod>2018-10-02T03:07:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-go-therapeutics-cancer-treatment/attachment/rochebasel-3/</loc>
		<lastmod>2018-10-03T07:20:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-raises-110m-financing-to-achieve-significant-milestones/attachment/business-deal-generic-aug-3/</loc>
		<lastmod>2018-10-03T08:12:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kite-hifibio-therapeutics-to-develop-technology-for-discovery-of-tcrs-to-treat-cancer/attachment/kite/</loc>
		<lastmod>2018-10-03T09:33:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alliance-pharma-xonvea-uk-launch/attachment/pills-generic-oct/</loc>
		<lastmod>2018-10-03T12:04:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-boston-pharmaceuticals/attachment/novartisbasel1-2/</loc>
		<lastmod>2018-10-04T07:29:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam-seeks-mhra-approval-to-start-aln-aat02-phase-1-2-trial/attachment/clinical-trial-generic-oct/</loc>
		<lastmod>2018-10-04T08:37:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-sciences-biktarvy-shows-high-efficacy-in-hiv-study/attachment/hivirus/</loc>
		<lastmod>2018-10-04T09:02:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/standardizing-the-quality-control-of-any-dna-isolation-to-safeguard-the-success-of-genetic-testing/attachment/ec81aa1d-67db-4ca7-ab3d-9afbb039f2f4/</loc>
		<lastmod>2018-10-04T09:25:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/all-purpose-protein-sample-qc-using-a-novel-micro-volume-platform-with-cdrop-software/attachment/8af1efa8-0ac6-4199-a550-0d7c7dbf9a60/</loc>
		<lastmod>2018-10-04T09:29:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/dropsense16-apps-rna-cy3cy5-and-ssdna-cy3cy5/attachment/21d19736-851b-421c-8e75-5a9aff10af5f/</loc>
		<lastmod>2018-10-04T09:32:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/dropsense16-app-rna-ffpe/attachment/6e188120-a5bc-4d21-9ae8-14ed385db643/</loc>
		<lastmod>2018-10-04T09:32:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/dropsense16-app-colorimetric-assays/attachment/a6a9326f-5286-4b30-8a07-389f22f1a49a/</loc>
		<lastmod>2018-10-04T09:35:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/dropsense16-app-a280-protein/attachment/ed1b0694-30d1-4d26-8de9-611d92cc8ad0/</loc>
		<lastmod>2018-10-04T09:36:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/dropsense16-app-rna/attachment/dea522c3-1128-41f4-a334-3c057a6213f5/</loc>
		<lastmod>2018-10-04T09:39:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/dropsense16-app-purified-pcr/attachment/63191322-66a5-4a4b-894b-52bbfb00ac6f/</loc>
		<lastmod>2018-10-04T09:40:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/dropsense16-app-culture-od600/attachment/55e7fce7-ad81-4de4-883a-59b63b13a23a/</loc>
		<lastmod>2018-10-04T09:41:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/dropsense16-app-dna-mammalian/attachment/3e820daa-6a2e-4ea2-a13e-0e5c62ceb1bf/</loc>
		<lastmod>2018-10-04T09:43:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/dropsense16-app-total-protein/attachment/b6172e95-56d0-40f4-94ed-d503d4490c9a/</loc>
		<lastmod>2018-10-04T09:44:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/empagliflozin-type-1-diabetes-trial/attachment/eli-lilly-headquarters-2/</loc>
		<lastmod>2018-10-04T12:24:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/qa-analysis/attachment/x-20150515163142046/</loc>
		<lastmod>2018-10-04T14:13:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/stability-storage-and-testing/attachment/stabillity_p-l/</loc>
		<lastmod>2018-10-04T14:17:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/method-development-and-validation/attachment/butterworth_product/</loc>
		<lastmod>2018-10-04T14:20:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/elemental-analysis/attachment/elemental-l/</loc>
		<lastmod>2018-10-04T14:22:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/residual-solvents/attachment/p_b_l/</loc>
		<lastmod>2018-10-04T14:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arrowhead-janssen-aro-hbv/attachment/arrowhiv/</loc>
		<lastmod>2018-10-05T07:55:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-hiv-therapy-delstrigo-achieves-primary-efficacy-endpoint-in-phase-3-study/attachment/hivmerck/</loc>
		<lastmod>2018-10-05T08:16:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/molnr-institute/whitepapers/visual-chromatography-modelling-and-optimisation-software/attachment/molnar-institute_executive-summary_webcast/</loc>
		<lastmod>2018-10-05T10:45:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/molnr-institute/attachment/drylab-logo-1/</loc>
		<lastmod>2018-10-05T10:55:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-merck-gardasil-9-hpv/attachment/fdadrug-3/</loc>
		<lastmod>2018-10-08T07:28:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sitryx-launches-with-30m-funding-to-develop-disease-modifying-therapeutics/attachment/research-lab-generic/</loc>
		<lastmod>2018-10-08T07:41:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hvivo-signs-new-contracts-with-global-biopharmaceutical-firm/attachment/contrac/</loc>
		<lastmod>2018-10-08T09:00:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/remote-sensing-technology-pharma/attachment/sigis2_scanning-imaging-remote-sensing-system-3/</loc>
		<lastmod>2018-10-08T11:01:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bial-eslicarbazepine-acetate-monotherapy/attachment/bial-portugal-1/</loc>
		<lastmod>2018-10-08T12:20:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/characterization-of-protein-protein-interactions-using-triple-detection-size-exclusion-chromatography-sec-td/attachment/7bd49ffd-9f30-4314-8082-4d7f0a485d8b/</loc>
		<lastmod>2018-10-08T12:43:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/comparing-the-rheology-and-particle-size-of-smoothies-made-with-different-blenders/attachment/7ae21f4e-e141-4f59-84a9-3b3f87b583cb/</loc>
		<lastmod>2018-10-08T12:45:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/evaluating-product-spreading-characteristics-on-a-rotational-rheometer-using-the-power-law-model/attachment/8b258797-26b5-40a2-a767-b78dc551431a/</loc>
		<lastmod>2018-10-08T12:48:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/analysis-of-demicellization-data-from-isothermal-titration-calorimetry/attachment/be16f759-ce2f-40c2-ba87-5e89b229b36b/</loc>
		<lastmod>2018-10-08T13:14:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/optimizing-fluid-rheology-for-enhanced-oil-recovery-applications/attachment/ff3e237f-686f-4c46-aef3-85d424d89aab/</loc>
		<lastmod>2018-10-08T13:16:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/characterization-of-igg-monomers-their-aggregates/attachment/58c10982-08b0-4ade-aa8d-e92dac8fd3ad/</loc>
		<lastmod>2018-10-08T13:20:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/optimization-of-plaplga-molecular-weight-and-structure-to-suit-final-application-requirements/attachment/4d05b75e-8392-4720-af58-101be68fe2c7/</loc>
		<lastmod>2018-10-08T13:23:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/differentiation-of-polymer-branching-and-composition-using-the-markhouwink-plot/attachment/e2428b52-a898-4c27-9e7c-7ff28234a2d2/</loc>
		<lastmod>2018-10-08T13:26:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/polyol-induced-increases-in-thermal-stability-of-antibodies-by-dsc/attachment/975c0281-605b-4dc2-9230-ad493ba92e56/</loc>
		<lastmod>2018-10-08T13:33:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/the-application-of-microcal-vp-capillary-dsc-at-a-contract-development-organization/attachment/222c0ca2-fc5e-4325-9ada-9371289c1e66/</loc>
		<lastmod>2018-10-08T13:37:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/engineering-monoclonal-antibodies-to-enhance-drugability/attachment/1f810b72-70fc-43ab-af85-4911b1daa2d7/</loc>
		<lastmod>2018-10-08T13:40:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/temperature-and-humidity-controlled-xrd/attachment/56a9c135-94a0-44f8-89ff-9860f6454d7b/</loc>
		<lastmod>2018-10-08T13:47:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/small-angle-x-ray-scattering-saxs/attachment/6742af18-d042-4c71-9d13-ad278b05d133/</loc>
		<lastmod>2018-10-08T13:54:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/on-line-crystallization-monitoring/attachment/7254fb39-7c8a-4f15-ba7c-0314a2587493/</loc>
		<lastmod>2018-10-08T13:58:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/case-study-supplying-costly-investigational-product-pre-randomisation-approach-reduces-drug-wastage/attachment/ef8dced5-9e86-4626-b507-902a72d0dbd9/</loc>
		<lastmod>2018-10-08T14:00:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/case-study-top-20-global-pharma-company-makes-cost-savings-of-almost-5m/attachment/bc1ddf1d-cbfd-437c-b37e-f7b54d8142de/</loc>
		<lastmod>2018-10-08T14:07:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/characterizing-the-microstructure-of-worm-like-micelles-using-rheology/attachment/4465cb17-c70c-4b15-a698-a60bb030f918/</loc>
		<lastmod>2018-10-08T14:12:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/measuring-the-particle-size-of-small-sample-volumes-using-laser-diffraction/attachment/52a0c8f5-38db-4dd5-b7f2-d89f9f2cf5ef/</loc>
		<lastmod>2018-10-08T14:14:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/use-of-microcalorimetry-and-its-correlation-with-size-exclusion-chromatography-for-rapid-screening-of-the-physical-stability-of-large/attachment/58dce80e-aab2-44f0-9935-5dfa8a62b19f/</loc>
		<lastmod>2018-10-08T14:17:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/microcalorimetry-as-a-tool-for-structural-biology/attachment/cfa5a9cc-4225-42d1-9114-4b07294b72b2/</loc>
		<lastmod>2018-10-08T14:19:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/discriminating-between-polymorphs-of-acetaminophen-using-morphologically-directed-raman-spectroscopy-mdrs/attachment/2d9a06b5-1326-48a7-9b76-14bb80381d23/</loc>
		<lastmod>2018-10-08T14:24:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/setting-a-new-standard-for-high-quality-powder-diffraction-dataand-more/attachment/763c9616-29f0-4b66-b23f-4a245e694645/</loc>
		<lastmod>2018-10-08T14:28:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/analysis-of-metals-in-pharmaceuticals/attachment/3132ec34-bdeb-4330-bd59-db4305828fd6/</loc>
		<lastmod>2018-10-08T14:30:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/characterization-of-protein-aggregates-in-suspension-and-on-a-filter-membrane-by-morphologically-directed-raman-spectroscopy/attachment/91d40c68-01d5-47cc-a2cc-c2471ee85cef/</loc>
		<lastmod>2018-10-08T14:33:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/determining-cure-profile-and-post-cure-shrinkage-of-photopolymers-using-uv-accessory-on-a-rotational-rheometer/attachment/0ce1183a-f6e2-4a98-b6be-22332ba87da3/</loc>
		<lastmod>2018-10-08T14:34:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/how-to-maximize-absolute-molecular-weight-measurement-accuracy-synthetic-polymers/attachment/6bd86930-2444-4142-9681-67407f74e917/</loc>
		<lastmod>2018-10-08T14:35:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/exploring-the-effect-of-carbon-microstructure-on-lithium-ion-battery-performance/attachment/21ec8092-be0c-47b3-9a2c-524c3b82ab56/</loc>
		<lastmod>2018-10-08T14:37:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/is-your-sample-dispersing-or-milling-hydro-sights-in-line-insight/attachment/d2260bd6-a583-491f-a2f2-f71a479450a6/</loc>
		<lastmod>2018-10-08T14:40:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/the-endometriosis-health-profile-successful-epro-collaboration/attachment/c0a8fedc-8274-449d-9370-4673749add53/</loc>
		<lastmod>2018-10-08T14:43:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/understanding-the-effect-of-polymer-structure-on-its-bulk-properties-how-to-optimize-for-end-use-application/attachment/76a9b5fb-52fa-4748-b232-b917e83a5568/</loc>
		<lastmod>2018-10-08T14:45:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/rapid-measurement-of-coffee-ground-particle-size-distributions-during-coffee-grinding-operations/attachment/54b9af43-69b2-4ecf-b3a0-192d6e93d25c/</loc>
		<lastmod>2018-10-08T14:48:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/non-aaqueous-zeta-potential-measurements-of-carbon-black-powders/attachment/7487b120-5f7f-4a60-9761-291249d0b20b/</loc>
		<lastmod>2018-10-08T15:03:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/assessing-the-self-association-and-stability-of-insulin-under-varying-formulation-conditions-using-taylor-dispersion-analysis/attachment/a99b1aec-f1db-4d79-8aae-003ec10bbd01/</loc>
		<lastmod>2018-10-08T15:05:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/determination-of-pressure-sensitive-tack-and-adhesion-using-axial-measurements-on-a-rotational-rheometer/attachment/25e158db-294d-4e41-9c80-4837e4ad667b/</loc>
		<lastmod>2018-10-08T15:08:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/assessing-tackiness-and-adhesion-using-a-pull-away-test-on-a-rotational-rheometer/attachment/7203ceec-1ad8-4bea-acf9-df67ca6f064c/</loc>
		<lastmod>2018-10-08T15:10:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/quantifying-shear-thickening-behaviour-using-the-power-law-model-on-a-rotational-rheometer/attachment/af01ae6c-2c70-4be2-a67d-e37fa6be0469/</loc>
		<lastmod>2018-10-08T15:12:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/nanosight-nta-concentration-measurement-upgrade/attachment/3c39f2eb-91d3-41d3-8905-7920decf0962/</loc>
		<lastmod>2018-10-08T15:13:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/relative-viscosity-screening-of-monoclonal-antibody-mab-formulations-at-low-concentration-and-low-viscosity-for-early-stage-developability/attachment/29599fec-6c4c-4cb9-9b2d-9eb65aa7377f/</loc>
		<lastmod>2018-10-08T15:16:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/assessing-the-self-association-behaviour-of-insulin-with-concentration-using-taylor-dispersion-analysis/attachment/108339d8-93e4-4d52-b57a-99c01b05197d/</loc>
		<lastmod>2018-10-08T15:18:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/compositional-insights-for-protein-mixtures-a-case-study-of-a-semi-pure-amylase/attachment/93a8d094-0da5-40b7-a351-3b1f4ba92147/</loc>
		<lastmod>2018-10-08T15:20:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/determining-fluorescence-limit-of-detection-with-nanoparticle-tracking-analysis-nta/attachment/1e55e754-4226-45f9-b76a-23b6998d8d1d/</loc>
		<lastmod>2018-10-08T15:32:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/implementation-of-kinitc-into-affinimeter/attachment/baf3e13a-3c02-4b8b-a408-565d4ddaf06c/</loc>
		<lastmod>2018-10-08T15:36:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/commercial-launch-partnering-solutions-take-charge-of-your-products-potential/attachment/527ef374-f3d5-4612-9483-3bae9b9757b7/</loc>
		<lastmod>2018-10-08T15:38:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/focusing-on-emerging-biopharma-a-tailored-solution-for-better-outcomes-a-tailored-solution-for-better-outcomes/attachment/0bd52f99-0786-4c88-92df-3053ead74019/</loc>
		<lastmod>2018-10-08T15:40:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/population-pkpd-modeling-and-simulation-optimisation-tools/attachment/2835e0ae-243d-488b-a2f3-13eca6663650/</loc>
		<lastmod>2018-10-08T15:42:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/transforming-trial-execution-for-faster-better-decisions/attachment/d96faff7-a8db-457e-9916-ecf193d39a0a/</loc>
		<lastmod>2018-10-08T15:44:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/quintiles-oncology-biomarker-services-comprehensive-support-for-fluid-and-tissue-based-testing/attachment/76cad4c8-6194-4459-b779-dac880d237a2/</loc>
		<lastmod>2018-10-08T15:46:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/air-treatment-cold-and-chill-stores-condensation-prevention/attachment/90549804-464c-403a-8240-4b16c993e2ed/</loc>
		<lastmod>2018-10-08T15:54:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inovio-develops-dna-encoded-monoclonal-antibody-checkpoint-inhibitor/attachment/clinical-trial-generic-oct-2/</loc>
		<lastmod>2018-10-09T07:32:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-ema-multiple-sclerosis-siponimod/attachment/novartisbasel-2/</loc>
		<lastmod>2018-10-09T07:38:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/etherna-immunotherapies-opens-mrna-manufacturing-facility-in-belgium/attachment/drugbel/</loc>
		<lastmod>2018-10-09T09:14:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diurnals-chronocort-phase-3-trial/attachment/clinical-trial-generic-july-11/</loc>
		<lastmod>2018-10-09T12:37:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/munters-icedry-revolution-in-coldstores/attachment/9527cb0c-3672-4053-b221-ee9741cec86a/</loc>
		<lastmod>2018-10-09T13:56:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/air-treatment/attachment/a58c81ad-33d3-4330-8716-0a95e108b344/</loc>
		<lastmod>2018-10-09T13:59:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/perfect-climate-for-pharmaceutical-manufacture/attachment/adef8f31-3a51-424b-a0ba-5b2a60cec30b/</loc>
		<lastmod>2018-10-09T14:03:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/reduced-running-costs-ingenious-and-efficient/attachment/fb18085c-256f-46ea-9e46-6464908f56da/</loc>
		<lastmod>2018-10-09T14:06:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/diagnostic-research-program-success/attachment/2f0968b0-8954-4d63-88f7-810c474697e0/</loc>
		<lastmod>2018-10-09T14:12:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/pras-unique-model-leads-to-client-satisfaction-project-team-uses-innovation-and-flexib/attachment/3e843ce7-10a3-4488-9887-7113ea086944/</loc>
		<lastmod>2018-10-09T14:14:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/pras-feasibility-leads-to-unique-enrollment-strategy/attachment/36defb52-d5d2-4651-990d-fc1fef18d02a/</loc>
		<lastmod>2018-10-09T14:17:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/pras-unique-model-leads-to-client-satisfaction/attachment/9a24fd69-3a1c-451c-85e6-e31f0bbd9a51/</loc>
		<lastmod>2018-10-09T14:18:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/challenging-study-timeline-goals-achieved-in-global-post-authorization-safety-study-pass/attachment/98387d8a-528b-4471-afce-6b3778ebddb7/</loc>
		<lastmod>2018-10-09T14:22:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/pra-delivers-study-start-up-success/attachment/431f5dea-aec2-4f0f-9102-2da10e79f244/</loc>
		<lastmod>2018-10-09T14:26:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/pra-optimal-recruitment-strategies-reduce-enrollment-timelines/attachment/71a8df43-8e08-44fe-ab5c-4df9ebaabf0c/</loc>
		<lastmod>2018-10-09T14:29:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/pra-rescues-diagnostic-cancer-study/attachment/a2f6dc47-b689-46a5-a87c-bfc20745e13b/</loc>
		<lastmod>2018-10-09T14:32:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/expanding-capacity-full-automatic-process/attachment/038e076e-356d-4343-bf9c-c0dc4fa48249/</loc>
		<lastmod>2018-10-09T14:36:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/measuring-small-quantities-of-dry-powder-using-the-aero-s-and-mastersizer-3000/attachment/eec2935a-6b05-4047-a951-c8c9bb0e8e8a/</loc>
		<lastmod>2018-10-09T14:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/measuring-small-volumes-of-nanoparticles-using-the-mastersizer-3000-and-hydro-sv/attachment/ef0bdcbd-3ab2-4c18-824e-8a702644b85b/</loc>
		<lastmod>2018-10-09T14:40:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/characterizing-opthalmic-viscosurgical-devices-ovds-using-a-rotational-rheometer/attachment/190fc1b0-c384-4fc3-adb4-c3165aed2e31/</loc>
		<lastmod>2018-10-09T14:43:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/detecting-the-presence-of-anomolous-large-particles-within-powders-using-laser-diffraction-particle-size-analysis/attachment/9576ea28-274e-468d-a1f7-75fbfe96b20d/</loc>
		<lastmod>2018-10-09T14:45:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/euticals-brochure/attachment/2abbb13c-f3f7-4d08-818c-fdf682b147d6/</loc>
		<lastmod>2018-10-09T14:47:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/datasheet-track/attachment/6eaaa72a-8f92-4854-99b1-9fed22cdf8f8/</loc>
		<lastmod>2018-10-09T15:02:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/pras-strategies-impress-client/attachment/b1e32f0b-b226-45e6-89cf-645a84227229/</loc>
		<lastmod>2018-10-09T15:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/strong-site-selection-leads-to-success/attachment/3cfe2bac-3de1-4550-8b62-7697f7ec3134/</loc>
		<lastmod>2018-10-09T15:06:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/pra-successfully-rescues-phase-ii-hematology-study/attachment/8328187a-0e3d-4448-88b1-02ef5d24a610/</loc>
		<lastmod>2018-10-09T15:09:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/meeting-enrollment-goals/attachment/ef4b7dea-348f-4823-999d-7f684d413912/</loc>
		<lastmod>2018-10-09T15:12:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/pra-exceeds-tough-enrollment-goals/attachment/e05efd81-98eb-469e-97df-241d0e02e1d8/</loc>
		<lastmod>2018-10-09T15:13:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/persistence-leads-to-high-enrollment/attachment/a6ef24fb-21bb-4935-801e-0fcf5c3e3ab9/</loc>
		<lastmod>2018-10-09T15:16:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/system-features/attachment/0ecf7f77-d960-4920-a411-2f93dfb3f8f8/</loc>
		<lastmod>2018-10-09T15:17:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/product-brochure/attachment/d103e4a6-fd7a-48f0-a431-db59fa280cca/</loc>
		<lastmod>2018-10-09T15:21:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/optional-modules-and-services/attachment/106742b8-379d-4977-a86b-02dd9bc63dd9/</loc>
		<lastmod>2018-10-09T15:23:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/klocke-uses-na-and-ml-for-quality-storage/attachment/35161d8d-42ac-42aa-9d7d-200c0df0d165/</loc>
		<lastmod>2018-10-09T15:25:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/gmp-compliance-with-help-from-munters-air-treatment-systems/attachment/81dfb167-f0fc-45bd-8c5a-1ea3f2676ad2/</loc>
		<lastmod>2018-10-09T15:29:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/munters-helps-fulfilling-fda-requirements/attachment/ae4aab2c-2c75-4eef-9526-c8d5778913d7-1/</loc>
		<lastmod>2018-10-09T15:32:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/dehumidified-automated-warehouse-at-novo-nordisk-as-awarded/attachment/30701487-b2e9-4a64-968d-3a48938f2446-1/</loc>
		<lastmod>2018-10-09T15:35:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/assessing-drug-encapsulation-efficiency-using-nanoparticle-tracking-analysis/attachment/c3596899-45ba-45be-9df4-0416fe669830/</loc>
		<lastmod>2018-10-09T15:39:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/gpc-characterisation-of-nylon-using-formic-acid-for-reduced-cost-per-analysis/attachment/192f263f-d6dc-4bca-a10b-b4227329199e/</loc>
		<lastmod>2018-10-09T15:41:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/biocatalysts-brochure/attachment/05396217-4bd3-4e52-81ae-c28c9f2225c7/</loc>
		<lastmod>2018-10-09T15:44:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/casestudies/the-directed-ortho-metallation-cross-coupling-fusion-development-and-application-in-synthesis/attachment/3d19b709-8275-40e1-a848-65e05b5c35a5/</loc>
		<lastmod>2018-10-09T15:49:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stelara-ulcerative-colitis-study/attachment/jjbuild/</loc>
		<lastmod>2018-10-10T07:21:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new-clinical-trial-for-alzheimers-disease-treatment-begins-in-uk/attachment/alzheimers-disease-web/</loc>
		<lastmod>2018-10-10T07:42:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurocrine-biosciences-jnana-therapeutics-to-discover-medicines-for-cns-disorders/attachment/cns-2/</loc>
		<lastmod>2018-10-10T08:59:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mundipharma-buys-spanish-biosimilars-company-cinfa-biotech/attachment/mundipharma-facility/</loc>
		<lastmod>2018-10-10T12:47:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mundipharma-buys-spanish-biosimilars-company-cinfa-biotech/attachment/mundipharma-facility-2/</loc>
		<lastmod>2018-10-10T12:49:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-panel-biosimilar-rituxan/attachment/bloodcan/</loc>
		<lastmod>2018-10-11T07:00:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/silence-therapeutics-launches-interim-european-injunction-application-against-alnylams-onpattro/attachment/lawsuit-generic-2/</loc>
		<lastmod>2018-10-11T07:26:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/maxcyte-begins-first-clinical-trial-in-solid-tumors/attachment/tumor/</loc>
		<lastmod>2018-10-11T08:23:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/%supplier_name%/news/179227/attachment/nsfbanner/</loc>
		<lastmod>2018-10-11T08:26:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/tosoh-bioscience/news/tosoh-bioscience-releases-new-hydroxyapatite-with-capure-ha/attachment/ca-pure/</loc>
		<lastmod>2018-10-11T14:27:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/tosoh-bioscience/whitepapers/oligonucleotide-purification-and-analysis/attachment/b17lp02a-oligonucleotide_brochure/</loc>
		<lastmod>2018-10-11T14:30:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-compugen-com701-opdivo-combo/attachment/bms/</loc>
		<lastmod>2018-10-12T06:50:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-compugen-com701-opdivo-combo/attachment/bristol-myers-squibb_pharmaceutical_research_institute-by-sue-adair-2/</loc>
		<lastmod>2018-10-12T06:54:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mei-beigene-to-evaluate-me-401-zanubrutinib-combo-in-b-cell-malignancies/attachment/clinical-research-lab-generic-3/</loc>
		<lastmod>2018-10-12T09:13:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/carrick-acquires-licensing-rights-of-btgs-ovarian-cancer-drug/attachment/business-agreement-signing-generic/</loc>
		<lastmod>2018-10-12T09:24:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/tosoh-bioscience/whitepapers/179284/attachment/mab-capture-analysis/</loc>
		<lastmod>2018-10-12T14:56:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mereo-bps-804-osteogenesis-imperfecta-drug-phase2b-trial/attachment/clinical-trial-generic-2-2-2/</loc>
		<lastmod>2018-10-15T06:52:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alliqua-biomedical-adynxx/attachment/adynx/</loc>
		<lastmod>2018-10-15T07:22:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr-reddys-to-sell-api-manufacturing-business-unit-in-hyderabad-india/attachment/acui/</loc>
		<lastmod>2018-10-15T08:40:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/maat-pharma-enrolls-first-patient-in-phase-2-clinical-trial-of-first-in-class-biotherapeutic-to-treat-acute-gvhd/attachment/trial-2/</loc>
		<lastmod>2018-10-15T08:50:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-kadcyla-breast-cancer/attachment/rochebasel-4/</loc>
		<lastmod>2018-10-16T07:16:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pci-completes-new-facility-for-clinical-trial-returns-in-uk/attachment/pci-clinical-services-announces-new-facility-dedicated-to-clinical-trial-returns_2_lr/</loc>
		<lastmod>2018-10-16T07:37:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hifibio-therapeutics-buys-an-early-stage-biotech-firm-h-immune-therapeutics/attachment/early/</loc>
		<lastmod>2018-10-16T09:39:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/revolution-medicines-warp-drive-bio/attachment/wapbio/</loc>
		<lastmod>2018-10-17T06:57:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quotient-opens-early-phase-formulation-and-manufacturing-facility-in-us/attachment/quotient-sciences-facility/</loc>
		<lastmod>2018-10-17T07:22:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-submits-nda-to-fda-for-kpi-121-0-25-to-treat-dry-eye-disease/attachment/human-eye/</loc>
		<lastmod>2018-10-17T08:21:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diurnal-adrenal-drug-chronocort-update/attachment/clinical-trial-generic-2-2-3/</loc>
		<lastmod>2018-10-17T14:00:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/temperature-sensitive-solutions/whitepapers/the-buyers-guide-to-real-time-temperature-monitoring/attachment/tss-buyers-guide-real-time-temperature-monitoring/</loc>
		<lastmod>2018-10-18T12:54:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/temperature-sensitive-solutions/whitepapers/beyond-the-call-of-duty/attachment/worldpharma-beyond-the-call-of-duty/</loc>
		<lastmod>2018-10-18T13:24:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/temperature-sensitive-solutions/whitepapers/investment-in-supply-chain-visibility-saves-costs/attachment/worldpharma-investment-in-supply-chain-visibility-saves-costs/</loc>
		<lastmod>2018-10-18T14:39:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/temperature-sensitive-solutions/whitepapers/keeping-the-cold-chain-on-the-level/attachment/worldpharma-keeping-the-cold-chain-on-the-level/</loc>
		<lastmod>2018-10-18T14:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/temperature-sensitive-solutions/whitepapers/stay-cool/attachment/worldpharma-stay-cool/</loc>
		<lastmod>2018-10-18T14:47:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/temperature-sensitive-solutions/whitepapers/temperature-check-for-pharmaceutical-supply-chains/attachment/worldpharma-temperature-check-for-pharmaceutical-supply-chains/</loc>
		<lastmod>2018-10-18T14:49:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-biopharmaceutical-endocyte/attachment/novartis-hq/</loc>
		<lastmod>2018-10-19T06:46:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvie-morphic-therapeutic-to-advance-therapeutic-for-fibrotic-diseases/attachment/abbvieus/</loc>
		<lastmod>2018-10-19T09:40:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-launches-phase-1-trial-of-ds-1205-in-egfr-mutated-nsclc/attachment/clinical-trial-generic-july-1-4/</loc>
		<lastmod>2018-10-19T09:49:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/videos/tss-transforming-the-supply-chain/attachment/image/</loc>
		<lastmod>2018-10-19T10:01:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/videos/how-to-manage-analytical-methods-using-one-chromatographic-modelling-tool/attachment/image-1/</loc>
		<lastmod>2018-10-19T10:02:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/videos/zenatek-going-beyond-the-known-limits/attachment/zenatek-video/</loc>
		<lastmod>2018-10-19T10:04:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-lynparza-ovarian-cancer/attachment/astratest/</loc>
		<lastmod>2018-10-22T07:39:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex-gets-european-chmp-positive-opinion-for-kalydeco-to-treat-cystic-fibrosis/attachment/cystic/</loc>
		<lastmod>2018-10-22T09:30:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tp-therapeutics-mezzanine-financing/attachment/business-agreement-signing-generic-2/</loc>
		<lastmod>2018-10-22T12:28:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/keytruda-overall-survival/attachment/keytruda/</loc>
		<lastmod>2018-10-23T08:03:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/temperature-sensitive-solutions/attachment/logo-1-2/</loc>
		<lastmod>2018-10-23T08:42:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/supply-chain-management/attachment/tssps-1/</loc>
		<lastmod>2018-10-23T09:09:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/mission-management/attachment/tssps-2/</loc>
		<lastmod>2018-10-23T09:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/powerful-analytics/attachment/tssps-3/</loc>
		<lastmod>2018-10-23T09:27:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/incident-management/attachment/tssps-4/</loc>
		<lastmod>2018-10-23T09:30:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/real-time-monitoring/attachment/tssps-5/</loc>
		<lastmod>2018-10-23T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fsd-pharma-to-acquire-therapix-biosciences/attachment/rawpix/</loc>
		<lastmod>2018-10-23T09:40:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stoke-therapeutics-series-b-financing/attachment/business-deal-may-30/</loc>
		<lastmod>2018-10-23T12:00:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/butterworth-laboratories-ltd-pbr/whitepapers/enhanced-sampling-and-calibration-procedures/attachment/butterworth-wp-1/</loc>
		<lastmod>2018-10-23T15:27:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/butterworth-laboratories-ltd-pbr/whitepapers/electronic-data-retention-is-virtualisation-our-saviour/attachment/butterworth-wp-2/</loc>
		<lastmod>2018-10-23T15:29:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/butterworth-laboratories-ltd-pbr/whitepapers/elemental-impurity-analysis-in-pharmaceuticals-2/attachment/butterworth-wp-3/</loc>
		<lastmod>2018-10-23T15:32:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jj-skincare-firm-ciz/attachment/jjbuilding/</loc>
		<lastmod>2018-10-24T07:19:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chinese-pharma-firm-deploys-infortrend-hybrid-cloud-storage-for-rd-data-back-up/attachment/clinical-trial-generic-july-12/</loc>
		<lastmod>2018-10-24T07:30:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/canbridge-wuxi-biologics-to-develop-biotherapeutics-for-rare-diseases/attachment/rare/</loc>
		<lastmod>2018-10-24T08:07:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bain-capital-pfizer-cerevel-therapeutics/attachment/pfizer-worldheadquartersentrance-dec/</loc>
		<lastmod>2018-10-24T11:49:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-roches-xofluza-influenza/attachment/rochebasel-5/</loc>
		<lastmod>2018-10-25T07:35:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion-dicerna-to-discover-rnai-therapies-for-complement-mediated-diseases/attachment/clinical-research-lab-generic-4/</loc>
		<lastmod>2018-10-25T08:31:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cipher-pharmaceuticals-launches-brinavess-in-canada/attachment/afheart/</loc>
		<lastmod>2018-10-25T09:06:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/sanofi-cepia-pbr/whitepapers/sanofi-cepia-product-list/attachment/san-ais_a4-ad-ev3-ssmansux-hd-181005/</loc>
		<lastmod>2018-10-25T10:21:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/sanofi-cepia-pbr/whitepapers/sanofi-active-ingredient-solutions-brochure/attachment/san-ais_brochure-externe-22x25cm-ev-final-bd-new-180906/</loc>
		<lastmod>2018-10-25T10:31:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-signs-clinical-trial-collaboration-deal-with-merck-and-pfizer/attachment/clinical-trial-generic-july-1-5/</loc>
		<lastmod>2018-10-26T06:46:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regeneron-eylea-syringe/attachment/eyetest/</loc>
		<lastmod>2018-10-26T07:24:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/halozyme-announces-first-clinical-dosing-in-phase-1-trial-of-bms-986179-with-enhanze-technology/attachment/dose/</loc>
		<lastmod>2018-10-26T08:21:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/3r-pharma-consulting-services/attachment/office-1209640_1280/</loc>
		<lastmod>2018-10-26T14:47:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/advice-on-regulatory-issues-pbr/attachment/gavel-2492011_1280/</loc>
		<lastmod>2018-10-26T14:58:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/courses-and-workshops-on-quality-aspects-pbr/attachment/workshop-1746275_1280/</loc>
		<lastmod>2018-10-26T15:05:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/evaluation-of-stability-studies-pbr/attachment/microscope-275984_1280/</loc>
		<lastmod>2018-10-26T15:09:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/quality-aspects-pbr/attachment/lab-217041_1280/</loc>
		<lastmod>2018-10-26T15:13:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/strategy-and-procedures-pbr/attachment/student-849825_1280/</loc>
		<lastmod>2018-10-26T15:19:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/esperions-bempedoic-acid-phase-3-trial/attachment/clinical-research-lab-generic-5/</loc>
		<lastmod>2018-10-29T06:30:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mayne-pharma-acquires-rights-for-psoriasis-corticosteroid-halobetasol-foam/attachment/business-deal-generic-jul-23-4/</loc>
		<lastmod>2018-10-29T09:32:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/7psolutionsbanner/</loc>
		<lastmod>2018-10-29T15:03:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/7p/</loc>
		<lastmod>2018-10-29T15:07:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/independent-environmental-and-security-monitoring-pbr/attachment/gl300w/</loc>
		<lastmod>2018-10-29T15:13:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/routewatch-vehicle-security-fleet-management-pbr/attachment/routewatch-app/</loc>
		<lastmod>2018-10-29T15:24:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/trailer-security-and-inventory-management-pbr/attachment/emm/</loc>
		<lastmod>2018-10-29T15:27:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/industrial-energy-efficiency-abb-pbr-product-2/attachment/abb-hq-lead/</loc>
		<lastmod>2018-10-29T15:35:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/industrial-energy-efficiency-abb-pbr-product-2/attachment/aluminum-story-header/</loc>
		<lastmod>2018-10-29T15:50:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/inspection-services-abb-pbr-product/attachment/presentation/</loc>
		<lastmod>2018-10-29T15:52:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/operational-excellence-abb-pbr-product/attachment/hr_1215_2header/</loc>
		<lastmod>2018-10-29T15:57:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/process-safety-abb-pbr-product-1/attachment/process-safety-wheel-1-1c97c59ecc1f463c09537ff0000433538/</loc>
		<lastmod>2018-10-29T16:01:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/project-services-abb-pbr-products/attachment/shutterstock_193018961_1/</loc>
		<lastmod>2018-10-29T16:02:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/abb-limited-pbr/whitepapers/integrity-management-for-downstream-oil-gas-facilities/attachment/c5647fa9-5dee-4c5b-ad4c-7def74ee519d/</loc>
		<lastmod>2018-10-29T16:14:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/accelrys-pharma-profile/attachment/untitled-7/</loc>
		<lastmod>2018-10-29T16:29:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/accelrys-new-product-business-process-consulting/attachment/x-20121219095828218/</loc>
		<lastmod>2018-10-29T16:39:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/accelrys-new-product-specialized-consulting-implementation-services-offered-by-accelrys/attachment/product-image/</loc>
		<lastmod>2018-10-29T16:48:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eqt-karo-pharma-acquisition/attachment/karo-pharma-hq/</loc>
		<lastmod>2018-10-30T05:34:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/grunenthal-nexium-vimovo-rights/attachment/grunenthal-hq/</loc>
		<lastmod>2018-10-31T06:29:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/terns-raises-80m-to-advance-drugs-for-treatment-of-nash-and-cancer/attachment/clinical-trial-generic-july-1-6/</loc>
		<lastmod>2018-10-31T06:44:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-opens-new-biorepository-in-maryland-us/attachment/thermo-fisher-scientific/</loc>
		<lastmod>2018-10-31T06:54:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/accuri__cytometers__flow__cytometry/attachment/drew-hays-206414-unsplash/</loc>
		<lastmod>2018-10-31T15:45:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/accuri__c6__flow__cytometer/attachment/louis-reed-747388-unsplash/</loc>
		<lastmod>2018-10-31T15:59:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/accuri__cytometers__flow__cytometry/whitepapers/cell__analysis__tool/attachment/c525c326-824b-415d-8ea5-95d4511149bb-1/</loc>
		<lastmod>2018-10-31T16:03:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/accuri__cytometers__flow__cytometry/whitepapers/cell__counting__technology/attachment/f5d489cd-677c-4bff-929b-a78015a211f6-1/</loc>
		<lastmod>2018-10-31T16:06:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/accuri__cytometers__flow__cytometry/whitepapers/multi__parametric__analysis/attachment/d34636f7-2406-4876-aca4-7783fd676491-1/</loc>
		<lastmod>2018-10-31T16:10:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/accuri__cytometers__flow__cytometry/whitepapers/research__laboratory/attachment/cf07c10e-2006-43fa-9a03-fe9f75f571e4-1/</loc>
		<lastmod>2018-10-31T16:12:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sandoz-fda-approval-hyrimoz/attachment/novartis-hq-basel-jan/</loc>
		<lastmod>2018-11-01T05:11:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viiv-healthcares-hiv-1-drug-fostemsavir-succeeds-in-phase-3-trial/attachment/clinical-research-lab-generic-6/</loc>
		<lastmod>2018-11-01T07:25:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-tango-to-partner-on-targeted-immuno-oncology-therapies/attachment/cancer-cell-generic-3/</loc>
		<lastmod>2018-11-01T07:33:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/medelpharm/attachment/medelpharm-sized-ld-2-1/</loc>
		<lastmod>2018-11-01T10:05:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/medelpharm/attachment/logo-250/</loc>
		<lastmod>2018-11-01T10:26:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/new-stylone-evolution-scale-up-and-powder-characterization-at-production-speed/attachment/medelpharm-pbr-ps1/</loc>
		<lastmod>2018-11-01T10:37:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/quadro-leading-process-equipment-innovation/attachment/medelpharm-pbr-ps2/</loc>
		<lastmod>2018-11-01T10:42:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/roller-compactors-mills-and-more/attachment/medelpharm-pbr-ps3/</loc>
		<lastmod>2018-11-01T10:46:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/stylcam-200r-high-speed-rotary-press-simulator/attachment/medelpharm-pbr-ps4/</loc>
		<lastmod>2018-11-01T10:48:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/stylone-research-robot-medelpharm/attachment/medelpharm-pbr-ps5/</loc>
		<lastmod>2018-11-01T10:49:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/venclyxto-mabthera-ec-approval/attachment/abbvie-hq/</loc>
		<lastmod>2018-11-02T05:24:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gw-announces-us-launch-of-cannabinoid-medicine-for-seizures/attachment/epidiolex-1/</loc>
		<lastmod>2018-11-02T07:35:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/verona-enrolls-last-patient-in-phase-2-trial-for-rpl554-in-copd/attachment/clinical-trial-generic-oct-3/</loc>
		<lastmod>2018-11-02T07:42:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion-wraps-up-1-2bn-acquisition-of-syntimmune/attachment/business-shake-hands-sep/</loc>
		<lastmod>2018-11-05T06:45:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-lung-cancer-lorbrena/attachment/pfizerwo/</loc>
		<lastmod>2018-11-05T07:25:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-recalls-ortho-novum-tablets-due-to-incorrect-veridate-dispenser-instructions/attachment/janssen-pharmaceuticals-ortho-novum-1-35/</loc>
		<lastmod>2018-11-05T08:40:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genkyotex-gkt831-phase-2-trial/attachment/clinical-trial-generic-oct-4/</loc>
		<lastmod>2018-11-05T12:27:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle-genetics-files-bla-with-fda-for-lymphoma-drug-adcetris/attachment/cancer-cell-generic-4/</loc>
		<lastmod>2018-11-06T07:38:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-infinity-opdivo-ipi-549/attachment/olympus-digital-camera/</loc>
		<lastmod>2018-11-06T07:56:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quotient-sciences-expands-formulation-and-manufacturing-operations-in-uk/attachment/formula/</loc>
		<lastmod>2018-11-06T08:13:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-covis-pharma-otc-drugs/attachment/astrazeneca-hq-5/</loc>
		<lastmod>2018-11-06T12:33:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/monitoring-equipment/attachment/tss-devices/</loc>
		<lastmod>2018-11-06T15:47:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/adapt_localization/attachment/nicola-nuttall-721063-unsplash/</loc>
		<lastmod>2018-11-07T16:37:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/desktop_publishing/attachment/norbert-levajsics-186341-unsplash/</loc>
		<lastmod>2018-11-07T16:43:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/localization_testing_engineering/attachment/rawpixel-579231-unsplash/</loc>
		<lastmod>2018-11-07T16:46:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/readability_tests/attachment/nicole-honeywill-730102-unsplash/</loc>
		<lastmod>2018-11-07T16:50:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/translation_process/attachment/rawpixel-678089-unsplash/</loc>
		<lastmod>2018-11-07T16:55:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-liver-diseases-maralixibat/attachment/shire_location/</loc>
		<lastmod>2018-11-08T07:05:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/irx-therapeutics-acquired-by-brooklyn-immunotherapeutics/attachment/business-agreement-signing-generic-3/</loc>
		<lastmod>2018-11-08T07:59:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glenmark-pharmaceuticals-plans-to-launch-phase-1-trial-in-solid-tumors/attachment/tumor-2/</loc>
		<lastmod>2018-11-08T08:22:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/advancell-nanomedicine/attachment/freestocks-org-126848-unsplash/</loc>
		<lastmod>2018-11-08T09:05:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/advancell-nanomedicine/attachment/logo-23/</loc>
		<lastmod>2018-11-08T09:06:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/dermal-application/attachment/rawpixel-797133-unsplash/</loc>
		<lastmod>2018-11-08T09:13:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/nasal-application/attachment/joseph-greve-539294-unsplash/</loc>
		<lastmod>2018-11-08T09:16:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/oral-application/attachment/anna-sastre-3401-unsplash/</loc>
		<lastmod>2018-11-08T09:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/platform-technology/attachment/rawpixel-611110-unsplash/</loc>
		<lastmod>2018-11-08T09:27:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/pre-clinical-rd-pipeline/attachment/rawpixel-593598-unsplash/</loc>
		<lastmod>2018-11-08T09:29:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/use-of-nanosight-sample-assistant-for-characterisation-of-exosomes/attachment/_en_assets_an171208nanosightsampleassistantexosomes-6_tcm50-56442-2/</loc>
		<lastmod>2018-11-08T11:44:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4d-pharma-ibs-drug-blautix-phase-2-trial/attachment/clinical-research-lab-generic-7/</loc>
		<lastmod>2018-11-08T12:11:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/akzo-nobel-salt/attachment/akzo1/</loc>
		<lastmod>2018-11-08T14:11:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/akzo-nobel-salt/attachment/logo-91/</loc>
		<lastmod>2018-11-08T14:15:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/sanal-quality-products/attachment/untitled-8/</loc>
		<lastmod>2018-11-08T14:20:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/sanal-unique-product-range/attachment/untitled-9/</loc>
		<lastmod>2018-11-08T14:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/api-services-chemical-development-almac/attachment/api-development-and-manufacture-early-phase-web-2/</loc>
		<lastmod>2018-11-08T14:56:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/biomarker-discovery-development/attachment/api-development-manufacture-early-phase1/</loc>
		<lastmod>2018-11-08T15:03:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/clinical-services/attachment/untitled-11/</loc>
		<lastmod>2018-11-08T15:09:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/clinical-technologies/attachment/commerical-drug-procurement/</loc>
		<lastmod>2018-11-08T15:12:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/clinical-trial-supply/attachment/ctsupp/</loc>
		<lastmod>2018-11-08T15:18:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/commercial-services/attachment/untitled-12/</loc>
		<lastmod>2018-11-08T15:22:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/pharmaceutical-development/attachment/untitled-13/</loc>
		<lastmod>2018-11-08T15:48:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/almac-drug-development/news/almac-group-supports-amicus-therapeutics-commercial-orphan-drug-product/attachment/amicus-pack2/</loc>
		<lastmod>2018-11-08T16:19:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/almac-drug-development/whitepapers/a-survival-guide-to-temperature-data-in-life-sciences-by-almac/attachment/ce99ef66-99eb-40cf-8cc3-be08c4a2dda4/</loc>
		<lastmod>2018-11-08T16:26:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/almac-drug-development/whitepapers/almac-changing-the-dynamics-of-temperature-controlled-shipping-solutions/attachment/fb54bbbc-3de8-4888-ad54-8455d846fcdc/</loc>
		<lastmod>2018-11-08T16:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/almac-drug-development/whitepapers/almac-crystallisation-of-pharmaceutical-compounds/attachment/a3aed5ca-1831-48a9-9977-7c2954c33bb6/</loc>
		<lastmod>2018-11-08T16:30:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/almac-drug-development/whitepapers/almac-explores-interactive-response-technology/attachment/94146c64-bb12-49d7-83e5-e45f3b8415d8/</loc>
		<lastmod>2018-11-08T16:33:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/almac-drug-development/whitepapers/almac-presents-modern-perspectives-on-peptide-synthesis-an-introduction/attachment/5dbb5b65-e2ff-48ec-b5b6-d8d3cb028f48/</loc>
		<lastmod>2018-11-08T16:38:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/almac-drug-development/whitepapers/sciences-radiolabelling-brochure/attachment/583955e5-8188-40c7-ba59-1ea693822744-2/</loc>
		<lastmod>2018-11-08T16:41:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/almac-drug-development/whitepapers/introducing-direct-to-patient-shipments/attachment/78937f39-f8fe-4888-8e17-9c49b202f695-2/</loc>
		<lastmod>2018-11-08T16:43:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/almac-drug-development/whitepapers/building-the-next-generation-irt-an-exclusive-look-under-the-hood-of-ixrs3/attachment/8424935d-0f8b-446d-8fd9-9596ecda6b5d-2/</loc>
		<lastmod>2018-11-08T16:45:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/almac-drug-development/whitepapers/providing-an-unparalleled-range-of-contract-pharmaceutical-development-and-manufacturing-services-globally-for-over-40-years/attachment/3b77b0b2-2bca-44d5-8bbe-7522b1caa58e-2/</loc>
		<lastmod>2018-11-08T16:49:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/almac-drug-development/whitepapers/commerical-packaging/attachment/7bdc10fc-9a7d-4205-9e91-609eb0a144b8-2/</loc>
		<lastmod>2018-11-08T16:51:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biotime-asterias-biotherapeutics/attachment/biotime-2/</loc>
		<lastmod>2018-11-09T07:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/visterra-begins-phase-1-clinical-study-of-monoclonal-antibody-vis649/attachment/kidney/</loc>
		<lastmod>2018-11-09T09:06:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/recursion-secures-nih-phase-2-sbir-grant-to-discover-senolytic-drug-candidates/attachment/clinical-research-lab-generic-8/</loc>
		<lastmod>2018-11-09T11:25:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/recursion-secures-nih-phase-2-sbir-grant-to-discover-senolytic-drug-candidates/attachment/clinical-trial-generic-july-13/</loc>
		<lastmod>2018-11-09T11:26:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gs-9674-phase-2-liver-study/attachment/liver/</loc>
		<lastmod>2018-11-12T07:56:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ferring-launches-nocdurna-in-us-to-treat-nocturia-due-to-np/attachment/nocdurna/</loc>
		<lastmod>2018-11-12T08:00:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ferring-launches-nocdurna-in-us-to-treat-nocturia-due-to-np/attachment/nocdurna-1/</loc>
		<lastmod>2018-11-12T08:00:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/harpoon-therapeutics-secures-70m-funds-to-advance-immunotherapy-programs/attachment/immuno-2/</loc>
		<lastmod>2018-11-12T09:57:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/whitepapers/discover-new-opportunities-for-your-api/attachment/961ad887-c6db-4edc-9bf4-6c927e2e9fad/</loc>
		<lastmod>2018-11-12T12:20:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/whitepapers/innovative-injection-systems-new-perspectives-new-possibilities/attachment/iis-broschuere-en/</loc>
		<lastmod>2018-11-12T12:23:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/180482/attachment/lts-transdermal-technologie-produktion-800x465/</loc>
		<lastmod>2018-11-12T15:32:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/transdermal-technologies/attachment/x-20140417095910328/</loc>
		<lastmod>2018-11-12T15:33:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/oral-thin-films-drug-delivery/attachment/lts-transdermal-oft-bild-3-en/</loc>
		<lastmod>2018-11-12T15:36:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/drug-delivery-transdermal-therapeutic-systems/attachment/lts-transdermal-tts-bild-4-en/</loc>
		<lastmod>2018-11-12T15:43:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nestle-health-science-aimmune/attachment/nestle/</loc>
		<lastmod>2018-11-13T07:12:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/crispr-maxcyte-expand-partnership-to-develop-immuno-oncology-therapies/attachment/cancer-cell-generic-5/</loc>
		<lastmod>2018-11-13T07:31:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tecentriq-priority-review-breast-cancer/attachment/rochebasel-6/</loc>
		<lastmod>2018-11-13T12:09:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/news/new-lts-webinar/attachment/lts-oral-thin-films/</loc>
		<lastmod>2018-11-14T09:55:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nextcure-secures-93m-funds-to-support-clinical-development-of-two-drug-candidates/attachment/drugtest/</loc>
		<lastmod>2018-11-14T10:20:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scientists-engineer-dna-encoded-monoclonal-antibodies-for-zaire-ebolavirus/attachment/ebola-copy/</loc>
		<lastmod>2018-11-14T10:31:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-synagis-us-rights-sobi/attachment/astrazeneca-hq-cambridge/</loc>
		<lastmod>2018-11-14T11:53:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle-genetics-begins-blood-cancer-trial-with-sea-bcma/attachment/bloodcancer/</loc>
		<lastmod>2018-11-15T09:01:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-applies-for-expanded-approval-for-imbruvica-in-europe/attachment/johnsonjohnson_hq_building/</loc>
		<lastmod>2018-11-15T10:00:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-epizyme-oncology-therapy-program/attachment/boehnger/</loc>
		<lastmod>2018-11-16T07:34:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/adaptive-correlation-better-dls-data-with-less-time-and-effort/attachment/_en_assets_an180430introadaptivecorrelation-6_tcm50-56237/</loc>
		<lastmod>2018-11-16T09:30:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nexus-pharmaceuticals-gets-fda-nod-for-arsenic-trioxide-injection-in-10mg-per-10ml-vial/attachment/arsenic/</loc>
		<lastmod>2018-11-16T09:34:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/fast-toothpaste-identification-by-fingerprint/attachment/_en_assets_ane4_18328_fast_toothpaste_identification_by_fingerprint_tcm50-55517/</loc>
		<lastmod>2018-11-16T09:35:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/combating-counterfeit-drugs/attachment/_en_assets_combating_counterfeit_drugs_tcm50-45639-1/</loc>
		<lastmod>2018-11-16T09:38:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/analysis-of-ultra-low-sulphur-fuels/attachment/_en_assets_epatier3sulfurfuels_tcm50-57065-1/</loc>
		<lastmod>2018-11-16T09:41:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/glass-disks-and-xrf-analysis/attachment/_en_assets_whitepaperinterconnectionofglassanalysis_tcm50-57137-4/</loc>
		<lastmod>2018-11-16T09:45:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/reducing-the-cost-of-cement-production/attachment/_en_assets_wp120509reducecostcementautoproccontrol-6_tcm50-52594/</loc>
		<lastmod>2018-11-16T09:48:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-imfinzi-fails-os/attachment/trial-3/</loc>
		<lastmod>2018-11-19T07:54:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-novartis-drug-promacta-for-first-line-saa/attachment/novartisbasel1-3/</loc>
		<lastmod>2018-11-19T09:11:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/haselmeier-self-injection/whitepapers/180742/attachment/self-administration-with-injection-systems-simplify-patients-everyday-lives-haselmeier/</loc>
		<lastmod>2018-11-19T14:44:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/haselmeier-self-injection/whitepapers/injection-pens-for-osteoporosis-therapy/attachment/injection-pens-for-osteoporosis-therapy-2/</loc>
		<lastmod>2018-11-19T14:45:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/axisd-self-injector-pen-pbr/attachment/x-20140117124618125/</loc>
		<lastmod>2018-11-19T16:19:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/haselmeier-d-flex/attachment/zl534g9/</loc>
		<lastmod>2018-11-19T16:20:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/i-pen-self-injector-pbr/attachment/x-20140218095847531/</loc>
		<lastmod>2018-11-19T16:26:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/i-pen-self-injector-pen-pbr/attachment/x-20140218095613812/</loc>
		<lastmod>2018-11-19T16:28:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/penlet-self-injector-pbr/attachment/x-20140117124743328/</loc>
		<lastmod>2018-11-19T16:30:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/self-injector-softpen-pbr/attachment/x-20140117124913625/</loc>
		<lastmod>2018-11-19T16:33:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-avelumab-javelin-ovarian/attachment/pfizerworldhead/</loc>
		<lastmod>2018-11-20T07:12:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aries-pharmaceuticals-gets-fda-nod-for-aemcolo-to-treat-travelers-diarrhea/attachment/e-coli-ag-res-mag/</loc>
		<lastmod>2018-11-20T09:00:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glycomimetics-uproleselan-phase-3/attachment/clinical-trial-generic-2-5/</loc>
		<lastmod>2018-11-20T12:29:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr-reddys-gets-favorable-decision-in-buprenorphine-and-naloxone-sublingual-film-patent-case/attachment/dr-_reddys_finished_dosage_facility_iii/</loc>
		<lastmod>2018-11-21T08:21:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/leo-pharma-pellepharm-form-760m-rare-skin-disease-collaboration/attachment/leo-pharma/</loc>
		<lastmod>2018-11-21T08:31:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gamifant-fda-approval-hlh/attachment/gamifant_10and50mg_vial_package_v1/</loc>
		<lastmod>2018-11-21T09:37:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-daurismo-diagnosed-aml/attachment/pfizerworldheadquartersentrance/</loc>
		<lastmod>2018-11-22T07:22:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-immuneering-to-work-on-ai-driven-ligand-identification-for-rare-hereditary-metabolic-diseases/attachment/discovery/</loc>
		<lastmod>2018-11-22T08:18:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/msp-kofel/attachment/logo-26/</loc>
		<lastmod>2018-11-22T10:35:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cambrex-avista-pharma-deal/attachment/generic-tablets/</loc>
		<lastmod>2018-11-22T11:58:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/attachment/cat-health-sciences/</loc>
		<lastmod>2018-11-22T13:44:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/attachment/malvern-experts/</loc>
		<lastmod>2018-11-22T13:48:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/porton-biopharma/attachment/logo-8-300x86/</loc>
		<lastmod>2018-11-22T16:02:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/porton-biopharma/attachment/newleada/</loc>
		<lastmod>2018-11-22T16:03:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/porton-biopharma/news/porton-biopharma-opens-new-facility-to-make-more-childhood-cancer-treatment/attachment/presentation-2/</loc>
		<lastmod>2018-11-22T16:35:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-kyowa-hakko-kirin-to-commercialize-anemia-drug-daprodustat-in-japan/attachment/gskuk/</loc>
		<lastmod>2018-11-23T07:09:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vineti-tessa-partner-to-advance-cancer-immunotherapies/attachment/cancer-cell-generic-aug-2/</loc>
		<lastmod>2018-11-23T08:17:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/camurus-gets-eu-nod-for-weekly-and-monthly-buvidal-for-opioid-dependence/attachment/pill/</loc>
		<lastmod>2018-11-23T10:02:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/luxturna-gene-therapy-eu-approval/attachment/luxturna-product-vial/</loc>
		<lastmod>2018-11-23T12:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/russell__finex__fine__mesh__separation__technology/news/classifying-bakery-products/attachment/banner-480-x-209-2/</loc>
		<lastmod>2018-11-23T15:37:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/the-effect-of-cognitive-load-and-habit-formation-on-plant-operations/attachment/nsf-pb-white-paper-the-effect-of-cognitive-load-habit-formation-in-pharmaceutical-plant-operations/</loc>
		<lastmod>2018-11-23T16:13:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/the-value-of-winning-the-talent-war-and-investing-in-education/attachment/nsf-pb-white-paper-why-did-my-plant-close-the-importance-of-winning-the-talent-war-investing-in-education/</loc>
		<lastmod>2018-11-23T16:15:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mundipharma-neulasta-biosimilar-pelmeg/attachment/mundipharma/</loc>
		<lastmod>2018-11-26T07:40:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/poxel-begins-part-2-of-phase-1a-study-for-nash-treatment-pxl065/attachment/trial-4/</loc>
		<lastmod>2018-11-26T10:24:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-fasenra-egpa-fda/attachment/astrazeneca-hq-6/</loc>
		<lastmod>2018-11-26T11:45:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actinogen-medical-enrolls-last-patient-in-phase-2-alzheimers-trial/attachment/clinical-research-lab-generic-9/</loc>
		<lastmod>2018-11-27T07:01:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-opdivo-yervoy/attachment/lungtrial/</loc>
		<lastmod>2018-11-27T07:44:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/181084/attachment/plasma/</loc>
		<lastmod>2018-11-27T10:32:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vedanta-biosciences-ve202-trial/attachment/clinical-trial-generic-july-1-7/</loc>
		<lastmod>2018-11-27T13:02:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vedanta-biosciences-ve202-trial/attachment/clinical-trial-generic-july-14/</loc>
		<lastmod>2018-11-27T13:09:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-genentech-jecure-therapeutics/attachment/jecure/</loc>
		<lastmod>2018-11-28T07:03:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/beigene-acquires-rights-to-zymeworks-zw25-and-zw49-bispecific-candidates-in-asia-pacific/attachment/hand-shake-generic-nov/</loc>
		<lastmod>2018-11-28T07:39:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-genentech-jecure-therapeutics/attachment/gene-2/</loc>
		<lastmod>2018-11-28T09:03:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qps-expands-us-phase-i-clinical-trial-capabilities/attachment/qps/</loc>
		<lastmod>2018-11-28T09:53:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cyxone-ms-drug-t20k-update/attachment/clinical-trial-nov/</loc>
		<lastmod>2018-11-28T13:16:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/a-basic-guide-to-particle-characterization/attachment/cdfd90a0-d1b8-45d3-bdae-3f5d44cbbc09/</loc>
		<lastmod>2018-11-28T15:13:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-celltrion-get-fda-nod-for-biosimilar-to-roches-cancer-drug-rituxan/attachment/aurishealth/</loc>
		<lastmod>2018-11-29T07:32:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-celltrion-get-fda-nod-for-biosimilar-to-roches-cancer-drug-rituxan/attachment/aurishealth-2/</loc>
		<lastmod>2018-11-29T07:34:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hookipa-darwinhealth-to-collaborate-on-immunotherapies-development/attachment/cancer-generic-cell-nov/</loc>
		<lastmod>2018-11-29T07:49:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/puretechs-vor-secures-us-patent-for-compositions-and-methods-to-treat-hematologic-malignancies/attachment/blood-drop/</loc>
		<lastmod>2018-11-29T10:13:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-gilenya-ms/attachment/novartishead/</loc>
		<lastmod>2018-11-30T05:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abcellera-autolus-partner-on-antibody-discovery-project/attachment/abcellar/</loc>
		<lastmod>2018-11-30T07:44:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wuxi-abl-bio-to-collaborate-on-multiple-bispecific-antibodies/attachment/clinical-research-lab-generic-2-2/</loc>
		<lastmod>2018-11-30T07:49:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/redx-rxc006-treat-fibrosis/attachment/lung/</loc>
		<lastmod>2018-12-03T07:49:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biopharmaceutical-firm-aprea-therapeutics-raises-e50m-in-financing/attachment/cancer-generic-cell-nov-2/</loc>
		<lastmod>2018-12-03T08:54:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/crown-laboratories-buys-select-otc-consumer-healthcare-brands-from-gsk/attachment/gsklondon-2/</loc>
		<lastmod>2018-12-03T10:43:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-zolgensma-fda-priority-review/attachment/novartis-hq-basel/</loc>
		<lastmod>2018-12-03T12:42:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-oncology-tesaro/attachment/gsk/</loc>
		<lastmod>2018-12-04T07:13:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/trigr-therapeutics-abl-bio-sign-license-agreement-for-bispecific-antibody-candidate/attachment/trigr/</loc>
		<lastmod>2018-12-04T09:09:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-celltrion-get-fda-nod-for-biosimilar-to-roches-cancer-drug-rituxan/attachment/fdareseacrh-4/</loc>
		<lastmod>2018-12-04T09:16:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pain-therapeutics-challenges-fda-decision-on-remoxy/attachment/fdareseacrh-3/</loc>
		<lastmod>2018-12-04T09:16:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/temperature-sensitive-solutions/attachment/lead-2/</loc>
		<lastmod>2018-12-04T11:06:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/deepmind-3d-structure-proteins/attachment/origami-casp-181127-r01_fig1-folding/</loc>
		<lastmod>2018-12-04T17:26:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jjs-darzalex-multiple-myeloma/attachment/jhq/</loc>
		<lastmod>2018-12-05T07:41:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ixico-secures-expanded-contract-from-major-biopharmaceutical-firm/attachment/rawpixel/</loc>
		<lastmod>2018-12-05T10:46:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tris-pharma-recalls-infants-liquid-ibuprofen-in-us/attachment/infants-ibuprofen/</loc>
		<lastmod>2018-12-06T06:57:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb-uk-research-development/attachment/digital-molecule/</loc>
		<lastmod>2018-12-06T08:14:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mereo-biopharma-oncomed-pharmaceuticals-proposes-merger-deal/attachment/onco-2/</loc>
		<lastmod>2018-12-06T08:50:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-covis-pharma/attachment/astrazeneca-hq-7/</loc>
		<lastmod>2018-12-06T12:38:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-imfinzi-fails-to-improve-os-in-head-and-neck-cancer-trial/attachment/astratrial/</loc>
		<lastmod>2018-12-10T07:53:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai-ucl-to-launch-phase-i-trials-of-e2814-for-alzheimers-disease/attachment/clinical-trial-nov-2/</loc>
		<lastmod>2018-12-10T07:55:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/french-pharma-firm-cristers-selects-adents-prodigi-serialisation-solution/attachment/drugpill/</loc>
		<lastmod>2018-12-10T10:21:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-vedanta-biosciences-collaboration/attachment/bristol-myers-squibb_pharmaceutical_research_institute-by-sue-adair-1/</loc>
		<lastmod>2018-12-10T12:36:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pci-expands-cold-chain-storage-capabilities-at-uk-site/attachment/hay-on-wye-1/</loc>
		<lastmod>2018-12-11T07:44:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam-silence-settlement/attachment/onpattro-2/</loc>
		<lastmod>2018-12-11T08:19:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/russell__finex__fine__mesh__separation__technology/news/screening-cosmetic-and-dusting-powders/attachment/cosmetic-powder-1/</loc>
		<lastmod>2018-12-11T08:47:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e-therapeutics-novo-nordisk-enter-into-research-collaboration-agreement/attachment/research-2/</loc>
		<lastmod>2018-12-11T10:28:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ra-pharma-zilucoplan-phase-2/attachment/clinical-trial-nov-3/</loc>
		<lastmod>2018-12-11T12:33:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/attachment/logo-145/</loc>
		<lastmod>2018-12-11T12:38:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/novo-nordisk-pharmatech/attachment/logo-5-e1534864369367/</loc>
		<lastmod>2018-12-11T12:44:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/attachment/logo-1-3/</loc>
		<lastmod>2018-12-11T12:45:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/circassia-astrazenecas-copd-tudorza/attachment/astraright/</loc>
		<lastmod>2018-12-12T08:18:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/versant-ventures-launches-new-biotech-firm-black-diamond-therapeutics/attachment/cancer-generic-cell-nov-3/</loc>
		<lastmod>2018-12-12T09:45:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/schrodinger-tb-alliance-collaborate-to-advance-tuberculosis-drug-discovery/attachment/drug/</loc>
		<lastmod>2018-12-12T11:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/weizmann-researchers-discover-new-neural-mechanism-underlying-anxiety/attachment/fainzilber/</loc>
		<lastmod>2018-12-13T09:32:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/x-chem-almirall-forge-dermatology-focused-drug-discovery-alliance/attachment/almirall_sant_celoni_2/</loc>
		<lastmod>2018-12-13T09:41:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-ac-immune-collaboration/attachment/ac-immmune-lab/</loc>
		<lastmod>2018-12-13T12:11:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/woodley-equipment-company-pbr/news/woodley-equipment-company-acquires-blinded-diagnostics/attachment/woodley-pr/</loc>
		<lastmod>2018-12-13T12:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amag-pharmaceuticals-perosphere/attachment/amag/</loc>
		<lastmod>2018-12-14T07:40:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-gets-ec-approval-for-self-administration-of-xolair-across-all-indications/attachment/novartishead-2/</loc>
		<lastmod>2018-12-14T10:22:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bausch-health-signs-stalking-horse-agreement-to-buy-synergy-pharmaceuticals/attachment/baush/</loc>
		<lastmod>2018-12-14T10:32:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/alpex-pharma-pbr-storefront/attachment/logo-57/</loc>
		<lastmod>2018-12-14T10:45:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/alpex-pharma-pbr-storefront/attachment/1-alpex/</loc>
		<lastmod>2018-12-14T11:18:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-celltrion-biosimilar-breast/attachment/fdareseacrh-5/</loc>
		<lastmod>2018-12-17T07:08:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/innovent-incyte-sign-deal-for-three-clinical-stage-product-candidates-in-china/attachment/innopate/</loc>
		<lastmod>2018-12-17T10:52:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-gets-positive-chmp-opinion-for-oncology-biosimilar/attachment/pfizerworld/</loc>
		<lastmod>2018-12-17T11:00:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c4xd-horizon-synthetic-lethality-targets/attachment/cancer-generic/</loc>
		<lastmod>2018-12-17T12:23:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vedanta-bacterial-consortium-candidate/attachment/clostridium/</loc>
		<lastmod>2018-12-18T07:26:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-reports-positive-results-for-fremanezumab-in-phase-iiib-migraine-trial/attachment/tevacanada2/</loc>
		<lastmod>2018-12-18T07:38:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fuji-pharma-acquires-minority-stake-in-alvotech/attachment/alvotech_facilit/</loc>
		<lastmod>2018-12-18T08:04:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/delsitech-innovare-to-develop-long-acting-hiv-therapy/attachment/clinical-trial-nov-4/</loc>
		<lastmod>2018-12-19T07:33:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-fibrogen-roxadustat/attachment/tablet/</loc>
		<lastmod>2018-12-19T07:36:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/delsitech-innovare-to-develop-long-acting-hiv-therapy/attachment/clinical-trial-nov-5/</loc>
		<lastmod>2018-12-19T07:36:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-molecular-partners-announce-immuno-oncology-collaboration/attachment/amgen/</loc>
		<lastmod>2018-12-19T09:17:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-gsk-consumer-healthcare-jv/attachment/pfizerworldheadquarters-jan/</loc>
		<lastmod>2018-12-19T12:23:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/taisho-offers-to-buy-bms-upsa-consumer-health-business-for-1-6bn/attachment/handbms/</loc>
		<lastmod>2018-12-20T07:47:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-scholar-rock-to-develop-therapies-for-fibrotic-diseases/attachment/id-100475063/</loc>
		<lastmod>2018-12-20T07:49:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kuehne-nagel-opens-pharma-and-healthcare-warehouse-in-slovenia/attachment/pharma/</loc>
		<lastmod>2018-12-20T09:02:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-lfb-group-cellforcure/attachment/novartisheadquar/</loc>
		<lastmod>2018-12-21T05:40:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-agenus-collaborate-on-development-of-immuno-oncology-therapies/attachment/tabgilead/</loc>
		<lastmod>2018-12-21T06:00:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lupin-awards-malt1s-licensing/attachment/sem/</loc>
		<lastmod>2018-12-24T08:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-ultomiris/attachment/haemolytic/</loc>
		<lastmod>2018-12-24T11:20:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scientists-develop-treatment-eye/attachment/cornea/</loc>
		<lastmod>2018-12-26T08:26:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/researchers-study-genetic-pcos/attachment/pcos/</loc>
		<lastmod>2018-12-26T11:24:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-kala-nda/attachment/daniil/</loc>
		<lastmod>2018-12-27T08:04:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/opiant-sanofi-licensing-deal/attachment/cannobis/</loc>
		<lastmod>2018-12-27T12:31:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-fda-approves-sanofis-new-pediatric-vaccine/attachment/sanofi-28thdec/</loc>
		<lastmod>2018-12-28T09:21:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-fda-approves-sanofis-new-pediatric-vaccine/attachment/sanofi-fda-28thdec/</loc>
		<lastmod>2018-12-28T09:27:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zydus-cadila-usfda-nod/attachment/zydus-biologics-ahmedabad/</loc>
		<lastmod>2018-12-31T09:54:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antengene-funds-cancer-candidates/attachment/antigene/</loc>
		<lastmod>2019-01-02T08:28:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nuvo-pharmaceuticals-completes-acquisition-of-revenue-generating-products-from-aralez-pharmaceuticals/attachment/nuvo/</loc>
		<lastmod>2019-01-02T10:36:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/promethera-investment-itochu/attachment/photo-1519120126473-8be7aedcd6c6-2/</loc>
		<lastmod>2019-01-02T11:22:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-sprycel-fda-approval/attachment/bristol_myers_squibb_moreton_wirral/</loc>
		<lastmod>2019-01-03T07:40:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ironwood-allergan-set-to-resolve-linzess-patent-litigation-with-mylan/attachment/allergan-westport-ireland/</loc>
		<lastmod>2019-01-03T08:03:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spectrum-pharmaceuticals-announces-full-enrollment-of-poziotinib-egfr-cohort-for-previously-treated-nsclc/attachment/lungcancer/</loc>
		<lastmod>2019-01-03T12:28:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/russell__finex__fine__mesh__separation__technology/news/grading-fruit-seeds/attachment/eco-treasures/</loc>
		<lastmod>2019-01-03T14:41:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/malvern__instruments__particle__size__analysis__measurement__solutions/news/albemarles-ribbon-cutting-ceremony/attachment/malvern/</loc>
		<lastmod>2019-01-03T15:24:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-acquisition-celgene/attachment/pomalyst-product-shot_img_2118/</loc>
		<lastmod>2019-01-04T03:26:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/otsuka-click-to-develop-digital-therapeutics-for-mdd/attachment/id-100220946/</loc>
		<lastmod>2019-01-04T08:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/deciphera-begins-clinical-trial-of-rebastinib-in-combination-with-carboplatin-for-advanced-or-metastatic-solid-tumors/attachment/virus/</loc>
		<lastmod>2019-01-04T08:46:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-alopecia-areata/attachment/pfizer/</loc>
		<lastmod>2019-01-04T09:41:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biontech-cancer-research-sanofi/attachment/cancerdeal/</loc>
		<lastmod>2019-01-07T07:32:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adaptive-genentech-to-collaborate-on-personalized-cellular-therapies-for-cancer/attachment/headquarters_shot/</loc>
		<lastmod>2019-01-07T07:47:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-exercises-option-on-second-hepatic-disease-target-from-collaboration-with-dicerna/attachment/boehnger-2/</loc>
		<lastmod>2019-01-07T08:28:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-yuhan-nash-partnership/attachment/in-the-lab-1-1251082/</loc>
		<lastmod>2019-01-07T12:22:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pci-to-invest-20m-in-biologic-medicines-and-advanced-injectable-delivery-forms/attachment/pci-invests-in-automated-assembly-of-autoinjectors-300dpi/</loc>
		<lastmod>2019-01-08T06:52:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/catalent-biologics-capacity-us-sites/attachment/drugfill/</loc>
		<lastmod>2019-01-08T07:30:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytoreason-pfizer-collaborate-on-machine-learning-model-of-immune-system-for-drug-discovery/attachment/pfizerworld-2/</loc>
		<lastmod>2019-01-08T08:18:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-acquisition-loxo-oncology/attachment/lilly-hq/</loc>
		<lastmod>2019-01-08T11:30:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-breakthrough-therapy-status-sickle-cell-disease-treatment-crizanlizumab/attachment/novartisheadquar-2/</loc>
		<lastmod>2019-01-09T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurobo-to-begin-clinical-trial-of-nb-01-in-adult-patients-with-diabetic-neuropathic-pain/attachment/nervous/</loc>
		<lastmod>2019-01-09T09:08:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/canbridge-wuxi-expand-rare-disease-partnership/attachment/photo-1537522067833-5ea8b58ea85a/</loc>
		<lastmod>2019-01-09T10:45:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-shire-acquisition-update/attachment/shire_location_in_lexington_ma-2/</loc>
		<lastmod>2019-01-09T16:10:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eusa-pharma-sylvant/attachment/eusa/</loc>
		<lastmod>2019-01-10T07:32:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/agenus-to-use-selexis-technology-to-produce-therapeutic-proteins/attachment/cancer-cell-generic-aug-3/</loc>
		<lastmod>2019-01-10T07:47:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elevian-insilico-collaborate-to-discover-drugs-for-aging/attachment/drugdiscover/</loc>
		<lastmod>2019-01-10T08:27:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/vetter_pharma_international/attachment/image-header/</loc>
		<lastmod>2019-01-10T09:45:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ocular-seeks-fda-nod-for-expanded-indication-of-dextenza-eye-treatment/attachment/human-eye-2/</loc>
		<lastmod>2019-01-11T07:20:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diurnal-secures-second-us-patent-for-chronocort/attachment/usptojamesmadisonbuildingsouthside/</loc>
		<lastmod>2019-01-11T08:28:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hvivo-achieves-primary-endpoint-in-phase-iib-viral-challenge-study-for-flu-v/attachment/virus-2/</loc>
		<lastmod>2019-01-11T09:09:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/charles-river-atomwise-drug-discovery/attachment/drugcapacity/</loc>
		<lastmod>2019-01-14T07:26:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ascletis-and-alphamab-announce-strategic-collaboration-and-licensing-agreement-for-anti-pd-l1-to-treat-hepatitis-b-and-other-viral-diseases/attachment/virus-cell/</loc>
		<lastmod>2019-01-14T08:11:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/raman-spectrometers-pharma/attachment/bravo-1l/</loc>
		<lastmod>2019-01-14T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/raman-spectrometers-pharma/attachment/bravo-1s/</loc>
		<lastmod>2019-01-14T09:34:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/puma-biotechnology-knight-therapeutics-sign-license-deal-to-commercialize-nerlynx-in-canada/attachment/deal-1/</loc>
		<lastmod>2019-01-14T11:32:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-tafamidis-priority-review-attr-cm/attachment/pfizer-hq/</loc>
		<lastmod>2019-01-15T03:48:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-tafamidis-priority-review-attr-cm/attachment/pfizerworldheadquartersentrance-2/</loc>
		<lastmod>2019-01-15T03:49:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/sofgen-cdmo/attachment/logo-procaps-pbr/</loc>
		<lastmod>2019-01-15T10:30:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/sofgen-cdmo/attachment/lead-procaps-pbr-1/</loc>
		<lastmod>2019-01-15T10:32:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/sofgen-cdmo/attachment/logo-procaps-pbr-2/</loc>
		<lastmod>2019-01-15T10:36:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-biomunex-bixab-antibody/attachment/therapeutic/</loc>
		<lastmod>2019-01-16T07:28:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/exelixis-announces-u-s-fda-approval-of-cabometyx-cabozantinib-tablets-for-previously-treated-hepatocellular-carcinoma/attachment/cabometyx_60mg_40mg_20mg/</loc>
		<lastmod>2019-01-16T08:15:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioharmony-therapeutics-boehringer-ingelheim-to-advance-bacteriophage-lysin-therapeutics-to-treat-f-multi-drug-resistant-bacterial-infection/attachment/bacteria/</loc>
		<lastmod>2019-01-16T08:29:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/juvenescence-closes-first-tranche-of-series-b-financing-for-further-growth-and-development/attachment/drug-2/</loc>
		<lastmod>2019-01-17T08:56:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/schott-pharmaceutical-packaging/attachment/schott-muellheim-4726x2454-15012019/</loc>
		<lastmod>2019-01-17T12:06:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acrotech-hematology-oncology-spectrum/attachment/drugonco/</loc>
		<lastmod>2019-01-18T07:07:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adc-therapeutics-announces-first-patient-dosed-in-phase-i-clinical-trial-of-adct-601-in-advanced-solid-tumors/attachment/clinical-trial-nov-3-3/</loc>
		<lastmod>2019-01-18T08:40:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vaccinex-announces-completion-of-enrollment-for-signal-huntingtons-disease-trial/attachment/hunchington/</loc>
		<lastmod>2019-01-18T09:26:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kyn-therapeutics-celgene-collaboration/attachment/id-100250735/</loc>
		<lastmod>2019-01-21T05:56:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/promentis-pharmaceuticals-commences-phase-2-studies-for-sxc-2023-targeting-novel-glutamatergic-mechanism/attachment/clinical-trial-nov-6/</loc>
		<lastmod>2019-01-21T06:50:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pci-pharma-services-announces-further-expansion-of-controlled-substance-storage/attachment/oxycodone/</loc>
		<lastmod>2019-01-22T08:07:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-approves-vertexs-cf-treatment-orkambi-for-children-aged-two-to-five-years/attachment/clubbingcf/</loc>
		<lastmod>2019-01-22T08:37:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nash-pharmaceuticals-announces-84-reduction-of-fibrosis-by-additional-lead-compound-in-second-pre-clinical-study-for-non-alcoholic-fatty-liver-disease/attachment/liver-2/</loc>
		<lastmod>2019-01-22T09:11:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/sanofi-cepia-pbr/whitepapers/184244/attachment/san-ais_brochure-externe-22x25cm-ev-final-bd-new-180906-2/</loc>
		<lastmod>2019-01-22T16:18:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-oncology-tesaro-2/attachment/gsk-house/</loc>
		<lastmod>2019-01-23T07:50:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/redx-rxc004-clinical-trial/attachment/clinical-trial-generic-1/</loc>
		<lastmod>2019-01-23T12:30:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biontech-to-acquire-antibody-generation-unit-of-mab-discovery/attachment/photo-1471864190281-a93a3070b6de/</loc>
		<lastmod>2019-01-24T06:43:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bridgebio-pharma-drug-research/attachment/druresearch/</loc>
		<lastmod>2019-01-24T07:36:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ironwood-pharmaceuticals-initiates-phase-1-trial-of-iw-6463/attachment/cns-3/</loc>
		<lastmod>2019-01-24T08:28:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/circassia-ait-airnovent-rights/attachment/photo-1528789408128-bf8999ce0091/</loc>
		<lastmod>2019-01-24T12:11:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/circassia-ait-airnovent-rights/attachment/photo-1528789408128-bf8999ce0091-2/</loc>
		<lastmod>2019-01-24T12:13:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clovis-rubraca-ovarian-cancer/attachment/ovariancancer/</loc>
		<lastmod>2019-01-25T03:46:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/navitor-pharmaceuticals-commences-phase-1-clinical-evaluation-of-nv-5138-for-treatment-resistant-depression/attachment/depression/</loc>
		<lastmod>2019-01-25T05:06:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sobi-synagis-astrazeneca/attachment/drug-3/</loc>
		<lastmod>2019-01-28T07:43:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nextpharma-to-acquire-santens-tampere-manufacturing-facility/attachment/santarn/</loc>
		<lastmod>2019-01-28T09:10:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eib-to-lend-e100m-to-orion-for-pharmaceutical-research-and-development/attachment/acf07869-af11-497e-b576-8e1c1e61f0a7/</loc>
		<lastmod>2019-01-28T09:33:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/continued-process-verification/attachment/nsf-pb-white-paper-continued-process-verification/</loc>
		<lastmod>2019-01-28T10:21:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/what-does-organisational-development-mean-to-you/attachment/nsf-pb-white-paper-what-does-the-term-organizational-development-mean-to-you/</loc>
		<lastmod>2019-01-28T10:28:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/ft-mir-routine-spectrometer-pharma/attachment/hts-xt_sampe_holder_invenio_bruker_optics/</loc>
		<lastmod>2019-01-28T11:15:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/ft-ir-research-spectrometer-pharma/attachment/confocheck_protein-quantification_invenio_bruker_optics/</loc>
		<lastmod>2019-01-28T11:18:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/ft-ir-research-spectrometer-pharma/attachment/tga_ir_netzsch_invenio_bruker_optics/</loc>
		<lastmod>2019-01-28T11:19:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/raman-spectrometers-pharma/attachment/ram-ii_ft-raman-module_invenio_bruker_optics/</loc>
		<lastmod>2019-01-28T11:22:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/ft-mir-routine-spectrometer-pharma/attachment/invenio_ftir-research-spectrometer-with-touch-panel-768x432/</loc>
		<lastmod>2019-01-28T12:07:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/destiny-pharma-xf-73-trial/attachment/id-100369068/</loc>
		<lastmod>2019-01-28T12:09:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex-secures-health-canada-approval-for-expanded-use-of-kalydeco/attachment/id-100373814/</loc>
		<lastmod>2019-01-29T07:21:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-leukemia-imbruvica-obinutuzumab/attachment/johnson/</loc>
		<lastmod>2019-01-29T07:28:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion-announces-phase-3-study-of-ultomiris-achieves-primary-objective-in-complement-inhibitor-naive-patients-with-ahus/attachment/bloodcell/</loc>
		<lastmod>2019-01-29T08:25:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shield-feraccru-aegis-ckd-study/attachment/id-100251774/</loc>
		<lastmod>2019-01-29T16:26:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lyndra-therapeutics-raises-55m-in-series-b-financing/attachment/photo-1523006480666-4debbb34a28d/</loc>
		<lastmod>2019-01-30T06:36:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-tak-003-dengue-vaccine/attachment/takeda/</loc>
		<lastmod>2019-01-30T07:02:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-and-lilly-announce-top-line-results-from-second-phase-3-study-of-tanezumab-in-osteoarthritis-pain/attachment/pfizerhq/</loc>
		<lastmod>2019-01-30T07:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-crenezumab-trials-futility/attachment/genetech/</loc>
		<lastmod>2019-01-30T11:58:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/15-valent-pneumococcal-vaccine/attachment/fdadrug-4/</loc>
		<lastmod>2019-01-31T07:39:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dewpoint-therapeutics-launches-with-60m-series-a-to-advance-proprietary-platform-for-drugging-condensates/attachment/id-100271789/</loc>
		<lastmod>2019-01-31T07:55:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/novo-nordisk-pharmatech/attachment/logo-67/</loc>
		<lastmod>2019-01-31T09:25:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eureka-therapeutics-announces-us-fda-clearance-of-ind-application-for-trial-of-et140202-artemis-t-cell-therapy/attachment/liverdisease/</loc>
		<lastmod>2019-01-31T11:21:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hitachi-chemical-to-acquire-apceth-biopharma/attachment/id-10097695/</loc>
		<lastmod>2019-02-01T06:46:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-meiragtx-retinal-diseases/attachment/jonson/</loc>
		<lastmod>2019-02-01T07:28:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fortress-biotech-announces-cael-101-strategic-partnership-with-alexion-pharmaceuticals/attachment/strategic/</loc>
		<lastmod>2019-02-01T09:07:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neuraxpharm-acquires-cns-specialty-pharma-company-farmax/attachment/konica-minolta-digital-camera/</loc>
		<lastmod>2019-02-04T07:32:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forxiga-type-1-diabetes/attachment/astratablet/</loc>
		<lastmod>2019-02-04T07:55:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/newron-completes-patient-enrollment-in-stars-study/attachment/brainhuman/</loc>
		<lastmod>2019-02-04T09:28:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/verseon-ve-1902-phase-1/attachment/in-the-lab-1-1251082-2/</loc>
		<lastmod>2019-02-04T11:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-keytruda-plus-chemotherapy/attachment/keytruda-100mg-4ml-vial-and-carton-2/</loc>
		<lastmod>2019-02-05T07:32:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iqvia-launches-iqvia-biotech-dedicated-to-emerging-biotech-and-biopharma-industry/attachment/id-100271789-2/</loc>
		<lastmod>2019-02-05T07:44:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai-and-purdue-pharma-present-efficacy-and-safety-data-from-second-pivotal-phase-3-insomnia-study/attachment/eisai_head_office/</loc>
		<lastmod>2019-02-05T08:17:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-kadcyla-early-breast-cancer/attachment/rochebasel-1/</loc>
		<lastmod>2019-02-05T11:49:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amprologix-wins-dhsc-backing-for-new-antibiotic/attachment/800px-quarryhouseleeds/</loc>
		<lastmod>2019-02-06T07:36:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-merck-m7824/attachment/gsk-house-2/</loc>
		<lastmod>2019-02-06T07:39:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/moderna-announces-dosing-of-first-monoclonal-antibody-encoded-by-mrna-in-clinical-trial/attachment/labtest/</loc>
		<lastmod>2019-02-06T09:28:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-medi8897-regulatory/attachment/astrazeneca-hq-8/</loc>
		<lastmod>2019-02-06T11:55:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/%supplier_name%/news/free-webinar-from-nsf-want-answers-to-your-big-problems-try-disruptive-thinking/attachment/feb-19-webinar-nsf/</loc>
		<lastmod>2019-02-06T15:38:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-blood-disorder-cablivi/attachment/fdadrug-5/</loc>
		<lastmod>2019-02-07T07:31:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pci-pharma-services-announces-bottling-line-expansion-at-rockford/attachment/pci-expands-bottling-capacity/</loc>
		<lastmod>2019-02-07T07:35:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/frazier-healthcare-partners-launches-recida-therapeutics-to-develop-novel-therapeutics-for-serious-antibiotic-resistant-infections/attachment/medicine-2/</loc>
		<lastmod>2019-02-07T08:13:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tamrx-launches-to-develop-pipeline-of-immuno-oncology-products-for-treatment-of-cancers/attachment/in-the-lab-1-1251082-3/</loc>
		<lastmod>2019-02-08T06:50:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-incyte-gvhd-jakafi/attachment/fdadrug-6/</loc>
		<lastmod>2019-02-08T07:20:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ligand-announces-omniab-partnership-with-genagon-therapeutics/attachment/drudiscovery/</loc>
		<lastmod>2019-02-08T08:11:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/finch-cp101-recurrent-c-difficile/attachment/fda_bldg/</loc>
		<lastmod>2019-02-11T08:18:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/russell__finex__fine__mesh__separation__technology/news/grading-separator-for-pharmaceutical-powders/attachment/esteve-1l/</loc>
		<lastmod>2019-02-11T09:46:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-galapagos-enter-into-collaboration-in-fibrosis-field/attachment/fiborsis/</loc>
		<lastmod>2019-02-11T10:48:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/samsung-bioepis-c-bridge-capital-to-develop-and-commercialize-next-generation-biosimilars-in-china/attachment/tabletchina/</loc>
		<lastmod>2019-02-11T10:56:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gileads-liver-selonsertib/attachment/liver-3/</loc>
		<lastmod>2019-02-12T07:34:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neotx-therapeutics-announces-immuno-oncology-clinical-trial-collaboration-with-astrazeneca/attachment/virus-3/</loc>
		<lastmod>2019-02-12T08:15:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/redx-rock2-potential-fibrosis/attachment/id-10078509/</loc>
		<lastmod>2019-02-12T11:52:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-ibm-to-integrate-blockchain-technology-into-clinical-trials/attachment/boehringer-ingelheim/</loc>
		<lastmod>2019-02-13T06:47:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-takes-action-against-17-companies-for-illegally-selling-products-claiming-to-treat-alzheimers-disease/attachment/fdadrug-8/</loc>
		<lastmod>2019-02-13T09:11:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinigen-us-rights-proleukin/attachment/tower-with-surrounding-buildings-image/</loc>
		<lastmod>2019-02-13T11:54:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mayne-pharma-launches-lexette-halobetasol-propionate-foam-0-05-in-the-us/attachment/800px-psoriasis2010a/</loc>
		<lastmod>2019-02-14T06:47:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-novartis-egaten-fascioliasis/attachment/novartis-hq-2/</loc>
		<lastmod>2019-02-14T07:30:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/worlds-largest-pharmaceutical-firm-selects-valgenesis-to-standardize-corporate-validation-process-enterprise-level/attachment/system/</loc>
		<lastmod>2019-02-14T08:53:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/hyperion-series-of-ftir-microscopes/attachment/hyperion_brochure_en-2/</loc>
		<lastmod>2019-02-14T11:23:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/invenio-r-intuitive-ftir-rd-spectrometer/attachment/invenio_brochure_en/</loc>
		<lastmod>2019-02-14T11:27:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/ram-ii-ft-raman-module/attachment/ramii_flyer_en-2/</loc>
		<lastmod>2019-02-14T11:30:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/7psolutions-logo/</loc>
		<lastmod>2019-02-14T11:38:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/platypus-02/</loc>
		<lastmod>2019-02-14T11:38:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/7psolutions-logo-test/</loc>
		<lastmod>2019-02-14T11:40:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/motif-bio-iclaprim-fda-update/attachment/800px-fda_bldg_51_-_main_entrance_5161374834/</loc>
		<lastmod>2019-02-14T11:49:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sk-arvelle-antiepileptic-cenobamate/attachment/epileptic/</loc>
		<lastmod>2019-02-15T07:15:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vor-biopharma-receives-42m-funds-to-advance-development-of-cell-therapy-product-candidate-for-acute-myeloid-leukemia/attachment/virus-4/</loc>
		<lastmod>2019-02-15T08:39:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/round-banner-test/</loc>
		<lastmod>2019-02-15T15:27:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/round-banner-_1/</loc>
		<lastmod>2019-02-15T15:55:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/round-banner-_2/</loc>
		<lastmod>2019-02-15T15:57:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/round-banner-_3/</loc>
		<lastmod>2019-02-15T16:04:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/round-banner/</loc>
		<lastmod>2019-02-15T16:06:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/round-banner-_4/</loc>
		<lastmod>2019-02-15T16:13:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/round-banner-_5/</loc>
		<lastmod>2019-02-15T16:16:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-mercks-bavencio-inlyta/attachment/pfizer-2/</loc>
		<lastmod>2019-02-18T08:15:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/artificial-intelligence-can-predict-survival-of-ovarian-cancer-patients/attachment/artificial/</loc>
		<lastmod>2019-02-18T08:54:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/logo-white-bkgd/</loc>
		<lastmod>2019-02-18T09:21:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/artificial-intelligence-can-predict-survival-of-ovarian-cancer-patients/attachment/eric/</loc>
		<lastmod>2019-02-18T09:25:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/decipher-biosciences-announces-research-collaboration-with-dendreon-to-identify-genomic-drivers-of-patient-response-to-sipuleucel-t/attachment/clinical-trial-generic-1-2/</loc>
		<lastmod>2019-02-18T09:35:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer-vitrakvi-loxo-195-rights/attachment/bayer-hq-2/</loc>
		<lastmod>2019-02-18T11:48:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bionomics-bnc21-ptsd-trial/attachment/stress/</loc>
		<lastmod>2019-02-19T07:32:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/knight-signs-latin-american-strategic-funding-deal-with-moksha8/attachment/knight/</loc>
		<lastmod>2019-02-19T08:30:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/innovent-chipscreen-biosciences-to-evaluate-combination-therapy-in-colorectal-cancer-patients/attachment/id-100369076/</loc>
		<lastmod>2019-02-19T08:35:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-entrectinib-polatuzumab-vedotin/attachment/roche/</loc>
		<lastmod>2019-02-19T11:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/sofgen-cdmo/attachment/softigel-pbr-lead/</loc>
		<lastmod>2019-02-19T15:49:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-keytruda-melanoma/attachment/keytruda-2/</loc>
		<lastmod>2019-02-20T07:31:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/innovation-pharmaceuticals-receives-new-patent-for-compounds-for-use-in-treatment-of-oral-mucositis/attachment/mouth/</loc>
		<lastmod>2019-02-20T09:01:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ftc-teva-reverse-payment-charges/attachment/750px-apexbuildinghighsmith/</loc>
		<lastmod>2019-02-20T11:10:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/softgels/attachment/banners-pbr-products-services_mesa-de-trabajo-1-copia-6/</loc>
		<lastmod>2019-02-20T16:33:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/unigel/attachment/banners-pbr-products-services_mesa-de-trabajo-1/</loc>
		<lastmod>2019-02-20T16:36:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/chewgels/attachment/banners-pbr-products-services_mesa-de-trabajo-1-copia-2/</loc>
		<lastmod>2019-02-20T16:38:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/nutraceutical-gummies-gummygels/attachment/banners-pbr-products-services_mesa-de-trabajo-1-copia-4/</loc>
		<lastmod>2019-02-20T16:40:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/omega-3-fish-oils/attachment/monographpieces-ps-8/</loc>
		<lastmod>2019-02-20T16:48:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/hormone-products/attachment/storefront-5/</loc>
		<lastmod>2019-02-20T16:50:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/other-drug-delivery-forms/attachment/lead-new/</loc>
		<lastmod>2019-02-20T16:51:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peloton-therapeutics-secures-150m-in-series-e-financing/attachment/id-100588818/</loc>
		<lastmod>2019-02-21T07:50:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/indivior-generic-suboxone-opioid/attachment/drug-4/</loc>
		<lastmod>2019-02-21T07:58:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sosei-heptares-doses-first-patient-in-trial-targeting-endocrine-disorders/attachment/stethotrial/</loc>
		<lastmod>2019-02-21T09:32:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-approves-blincyto-in-patients-with-philadelphia-chromosome-negative-minimal-residual-disease-positive-b-cell-precursor-all/attachment/amgenheadquarters/</loc>
		<lastmod>2019-02-22T06:48:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-immune-design-300m/attachment/immuno-3/</loc>
		<lastmod>2019-02-22T07:12:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/morphic-therapeutic-enters-into-integrin-research-and-development-collaboration-with-janssen/attachment/drugresearch/</loc>
		<lastmod>2019-02-22T08:08:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvie-voyager-gene-therapy/attachment/abbviehq-2/</loc>
		<lastmod>2019-02-25T07:21:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/finch-cp101-recurrent-c-difficile/attachment/fdadrug-7/</loc>
		<lastmod>2019-02-25T08:18:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/urovant-sciences-signs-100m-debt-financing-agreement-with-hercules-capital/attachment/drug-5/</loc>
		<lastmod>2019-02-25T08:19:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsen-acquisition-clementia/attachment/mon-photo-1519120126473-8be7aedcd6c6/</loc>
		<lastmod>2019-02-25T12:01:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-acquisition-spark-therapeutics/attachment/roche-location/</loc>
		<lastmod>2019-02-26T06:30:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/danaher-ge-biopharma-21-4bn/attachment/danaher/</loc>
		<lastmod>2019-02-26T06:54:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-to-pursue-transformational-therapy-to-reduce-risk-of-cardiovascular-disease/attachment/novartis-hq-3/</loc>
		<lastmod>2019-02-26T09:10:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/bruker-optics-solutions-for-data-integrity-in-a-pharmaceutical-environment/attachment/whitepaper_data-integrity/</loc>
		<lastmod>2019-02-26T15:40:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imbrium-therapeutics-and-tetragenetics-announce-strategic-research-collaboration-and-license-option-to-develop-novel-biologic-therapeutics-for-pain/attachment/id-100271792/</loc>
		<lastmod>2019-02-27T06:47:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardiovascular-anthos-therapeutics/attachment/pfizerworld-3/</loc>
		<lastmod>2019-02-27T07:09:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardiovascular-anthos-therapeutics/attachment/novartis-hq-4/</loc>
		<lastmod>2019-02-27T08:07:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bausch-health-to-buy-certain-assets-of-synergy-pharmaceuticals/attachment/baushhelat/</loc>
		<lastmod>2019-02-27T08:20:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gdnf-trial-parkinsons-disease/attachment/getimage/</loc>
		<lastmod>2019-02-27T12:05:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/axial-biotherapeutics-raises-25m-in-series-b-financing/attachment/id-100286441/</loc>
		<lastmod>2019-02-28T06:39:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-farxiga-xigduo-xr/attachment/astratablet-2/</loc>
		<lastmod>2019-02-28T07:29:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nuformix-announces-mhra-approval-to-commence-nxp001-human-pharmacokinetics-studies/attachment/drugpill-2/</loc>
		<lastmod>2019-02-28T08:28:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/raman-spectrometers-pharma/attachment/test/</loc>
		<lastmod>2019-02-28T08:43:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/a-consult/attachment/lead-3/</loc>
		<lastmod>2019-02-28T14:50:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/a-consult/attachment/logo-85/</loc>
		<lastmod>2019-02-28T14:51:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/porton-biopharma/news/pbl-takes-on-its-first-apprentice/attachment/will-tucker-pbl/</loc>
		<lastmod>2019-02-28T15:13:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/horizons-phase-3-trial-for-teprotumumab-in-active-thyroid-eye-disease-meets-primary-endpoint/attachment/id-100220946-2/</loc>
		<lastmod>2019-03-01T06:49:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/maze-therapeutics-genetic-insights/attachment/tablet-2/</loc>
		<lastmod>2019-03-01T07:27:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-herceptin-hylecta-for-subcutaneous-injection-in-certain-her2-positive-breast-cancers/attachment/rochebuild/</loc>
		<lastmod>2019-03-01T08:06:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/russell__finex__fine__mesh__separation__technology/news/sieving-technologies-for-pharma-powders/attachment/contained-pharma-pbr/</loc>
		<lastmod>2019-03-01T15:43:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-lorviqua-marketing-authorization/attachment/pfizerworld-4/</loc>
		<lastmod>2019-03-04T05:44:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sagent-pharmaceuticals-announces-acquisition-of-raleigh-manufacturing-site/attachment/id-10015908/</loc>
		<lastmod>2019-03-04T07:50:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abpro-njcttq-partner-to-develop-multiple-bispecific-antibody-therapies/attachment/pill-2/</loc>
		<lastmod>2019-03-04T10:42:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/feraccru-phase-3-non-inferiority-study/attachment/red-blood/</loc>
		<lastmod>2019-03-04T11:36:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen-nightstar-therapeutics/attachment/biogen/</loc>
		<lastmod>2019-03-05T06:52:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/geovax-leidos-expand-collaboration-to-malaria-vaccines/attachment/mosquito/</loc>
		<lastmod>2019-03-05T09:18:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ensifentrine-dpi-phase-2-results/attachment/id-100271789-3/</loc>
		<lastmod>2019-03-05T11:45:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/managing-change/attachment/nsf-pb-white-paper-managing-change/</loc>
		<lastmod>2019-03-05T16:16:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/news/lts-ag-donates-pediatric-anaesthesia-trolley-to-st-nikolaus-stifts-hospital/attachment/ltslohmann-kindernarkosewagen-800x485/</loc>
		<lastmod>2019-03-05T16:30:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/news/esocap-announces-kick-off-of-an-industrial-development-collaboration-with-lts/attachment/ltslohmann-transdermal-esocap-800x458/</loc>
		<lastmod>2019-03-05T16:36:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-spravato-nasal-spray/attachment/spravato-esketamine-ciii-nasal-spray/</loc>
		<lastmod>2019-03-06T07:18:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ligand-sells-promacta-assets-and-royalty-for-827m/attachment/ligand/</loc>
		<lastmod>2019-03-06T08:12:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ozempic-sustain-9-diabetes-trial/attachment/novo_nordisk_hq-exterior-night-lowres2/</loc>
		<lastmod>2019-03-06T11:58:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imperial-college-says-hiv-remission-achieved-in-second-patient/attachment/newseventsimage_1551726031575_mainnews2012_x1/</loc>
		<lastmod>2019-03-07T06:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nice-blood-cancer-blincyto/attachment/virus-5/</loc>
		<lastmod>2019-03-07T07:23:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/beam-therapeutics-secures-135m-funds-to-expand-pipeline-of-precision-genetic-medicines/attachment/pharma-2/</loc>
		<lastmod>2019-03-07T08:13:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gtx-oncternal-therapeutics-oncology/attachment/cancer/</loc>
		<lastmod>2019-03-08T06:15:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viiv-healthcare-reports-positive-data-for-two-phase-3-hiv-trials-of-cabotegravir-rilpivirine-regimen/attachment/id-10078506/</loc>
		<lastmod>2019-03-08T06:50:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-announces-data-from-two-studies-supporting-further-development-of-investigational-hiv-1-capsid-inhibitor-gs-6207/attachment/hiv/</loc>
		<lastmod>2019-03-08T09:44:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-kinaxiss-rapidresponse-supply-chain/attachment/novartis-hq-5/</loc>
		<lastmod>2019-03-08T12:53:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/molnr-institute/whitepapers/understanding-the-impact-of-critical-method-parameters-at-first-glance/attachment/procuct-presentation_january_february-edition-converted-compressed/</loc>
		<lastmod>2019-03-08T14:09:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/taiwanj-pharmaceuticals-obtained-26m-deal-for-licensing-and-co-development-contract-with-newsoara-biopharma-on-jkb-122-asian-rights/attachment/mar-11photo-1518169640858-0d622b058e5c/</loc>
		<lastmod>2019-03-11T06:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-tecentriq-avastin/attachment/roche-location-2/</loc>
		<lastmod>2019-03-11T07:47:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nallian-to-launch-global-pharma-tracker-early-adopter-program/attachment/gpt-general/</loc>
		<lastmod>2019-03-11T07:59:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dupixent-fda-priority-review-crswnp/attachment/photo2_1539896880300-hr/</loc>
		<lastmod>2019-03-11T12:15:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/exploring-the-relationship-between-ivdr-and-the-ivdd/attachment/hs_mal__1903_ivdrwhitepaper/</loc>
		<lastmod>2019-03-11T14:09:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinical-stage-biotech-company-inventisbio-closes-70m-series-c-financing/attachment/business-3152586_960_720/</loc>
		<lastmod>2019-03-12T06:44:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-oncology-biosimilar-trazimera/attachment/pfizerworld-5/</loc>
		<lastmod>2019-03-12T07:25:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tenax-therapeutics-recruits-first-patient-in-phase-2-pulmonary-hypertension-clinical-trial/attachment/pulmonary/</loc>
		<lastmod>2019-03-12T08:58:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seres-astrazeneca-microbiome-oncology/attachment/cq5dam-web-1200-cgi-aerial-view/</loc>
		<lastmod>2019-03-12T12:05:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fujifilm-biogen-biologics-manufacturing/attachment/biogen-2/</loc>
		<lastmod>2019-03-13T07:15:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer-drug-parkinsons-patients/attachment/id-100220917/</loc>
		<lastmod>2019-03-13T12:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioarctic-announces-start-of-phase-1-study-of-abbv-0805-for-parkinsons-disease/attachment/laboratory-768x512/</loc>
		<lastmod>2019-03-14T06:57:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/esperions-cholesterol-bempedoic-acid/attachment/bempedoic/</loc>
		<lastmod>2019-03-14T07:24:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-iktos-ai-technology/attachment/ai-drug/</loc>
		<lastmod>2019-03-15T07:10:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xeris-pharmaceuticals-doses-first-patient-in-phase-2-trial-to-assess-ready-to-use-glucagon/attachment/gluco/</loc>
		<lastmod>2019-03-15T08:07:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biohaven-enrolls-first-patient-in-phase-3-spinocerebellar-ataxia-clinical-trial-of-troriluzole/attachment/blood-20745_960_720/</loc>
		<lastmod>2019-03-18T06:52:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/blackstone-specialty-pharmaceutical-ayumi/attachment/ayumi/</loc>
		<lastmod>2019-03-18T07:58:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/european-commission-approves-roches-mabthera-for-rare-autoimmune-disease/attachment/roche-2/</loc>
		<lastmod>2019-03-18T10:51:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/heart-drug-sudden-cardiac-arrest/attachment/medicine-1851178_960_720/</loc>
		<lastmod>2019-03-18T12:43:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/epsilon-1-small-and-powerful/attachment/epsilon-1/</loc>
		<lastmod>2019-03-18T16:14:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/epsilon-1-focus-on-the-details-to-capture-the-bigger-picture/attachment/epsilon-1-for-small-spot-analysis/</loc>
		<lastmod>2019-03-18T16:19:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/xrf-in-the-hands-of-scientists/attachment/epsilon-1-research-and-education_/</loc>
		<lastmod>2019-03-18T16:20:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imara-closes-a-63m-series-b-cross-over-financing/attachment/agreement-3489902_960_720/</loc>
		<lastmod>2019-03-19T06:41:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-tecentriq-chemotherapy/attachment/archivnummer-4076/</loc>
		<lastmod>2019-03-19T07:49:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ono-enters-into-research-collaboration-agreement-with-twoxar/attachment/tablet-4/</loc>
		<lastmod>2019-03-19T11:15:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-gardp-develop-antibiotics/attachment/laboratory-3827738_960_720/</loc>
		<lastmod>2019-03-19T11:50:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sage-therapeutics-postpartum-depression-zulresso/attachment/fdadrug-10/</loc>
		<lastmod>2019-03-20T07:40:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-kgaa-pfizer-discontinue-phase-iii-javelin-ovarian-parp-100-trial/attachment/pfizerworld-6/</loc>
		<lastmod>2019-03-20T09:18:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epigenetic-protein-aml-study/attachment/basheeretal/</loc>
		<lastmod>2019-03-20T12:18:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mundipharma-launches-invokana-and-vokanamet-in-norway-for-treatment-of-type-2-diabetes/attachment/mundipharma_3-472-of-478/</loc>
		<lastmod>2019-03-21T06:53:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-vivet-therapeutics/attachment/pfizerworldhead-2/</loc>
		<lastmod>2019-03-21T07:29:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-ngm-bio-extend-multi-year-strategic-collaboration/attachment/drug-6/</loc>
		<lastmod>2019-03-21T09:18:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imago-biosciences-announces-40m-series-b-financing-led-by-omega-funds/attachment/fri-agreement-3489902_960_720/</loc>
		<lastmod>2019-03-22T06:45:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anti-bcma-antibody-drug/attachment/gsk-2/</loc>
		<lastmod>2019-03-22T07:25:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/conatus-announces-top-line-results-from-encore-nf-phase-2b-clinical-trial-in-nash-fibrosis/attachment/liver-4/</loc>
		<lastmod>2019-03-22T08:47:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bluebird-bio-opens-gene-and-cell-therapy-manufacturing-facility-in-north-carolina/attachment/science-1029385_960_720/</loc>
		<lastmod>2019-03-25T06:35:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermo-fisher-brammer-bio/attachment/architectural-details-of-new-thermo-fisher-scientific-hq-in-waltham-ma-02451/</loc>
		<lastmod>2019-03-25T07:44:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-seeks-expanded-use-of-darzalex-combination-therapy-for-patients-with-newly-diagnosed-multiple-myeloma/attachment/virus-6/</loc>
		<lastmod>2019-03-25T08:51:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evgens-sfx-01-stem-trial/attachment/laboratory-3827745_960_720/</loc>
		<lastmod>2019-03-25T11:39:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arch-oncology-raises-50m-series-b-financing/attachment/cancer-cells-541954_960_720/</loc>
		<lastmod>2019-03-26T06:47:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer-janssen-litigation-xarelto/attachment/bayer/</loc>
		<lastmod>2019-03-26T07:44:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-forxiga-approved-in-europe-for-type-1-diabetes/attachment/astratablet-3/</loc>
		<lastmod>2019-03-26T08:27:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aimmune-peanut-allergy-drug-ar101/attachment/nuts-1736520_960_720/</loc>
		<lastmod>2019-03-26T11:52:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transgene-bioinvent-extend-collaboration-to-develop-multifunctional-oncolytic-viruses-for-treatment-of-solid-tumors/attachment/mitosis-3876669_960_720/</loc>
		<lastmod>2019-03-27T06:56:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/silences-sln124-%ce%b2-thalassemia/attachment/id-100277292/</loc>
		<lastmod>2019-03-27T12:12:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/silence-therapeutics-sln124/attachment/id-100277292-2/</loc>
		<lastmod>2019-03-27T12:12:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medpharm-to-develop-new-xf-drug-formulations/attachment/test-214186_960_720/</loc>
		<lastmod>2019-03-28T06:48:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer-research-uk-lifearc-ono-pharma-establish-new-drug-discovery-alliance/attachment/drug-7/</loc>
		<lastmod>2019-03-28T07:32:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer-research-uk-lifearc-ono-pharma-establish-new-drug-discovery-alliance/attachment/lab_work_hero/</loc>
		<lastmod>2019-03-28T08:08:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-forxiga-approved-in-japan-for-type-1-diabetes/attachment/tablet-5/</loc>
		<lastmod>2019-03-28T09:11:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-invests-in-expansion-of-manufacturing-capacity-for-biotech-medicines/attachment/merck-s-biotech-manufacturing-site-in-aubonne/</loc>
		<lastmod>2019-03-29T06:44:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-treatment-for-patients-with-non-radiographic-axial-spondyloarthritis/attachment/fdadrug-11/</loc>
		<lastmod>2019-03-29T08:12:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-daiichi-sankyo/attachment/researchdrug/</loc>
		<lastmod>2019-03-29T09:40:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/attachment/2-round-banner/</loc>
		<lastmod>2019-03-29T15:52:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/independent-environmental-and-security-monitoring-pbr/attachment/6-gd100-picture-1s/</loc>
		<lastmod>2019-03-29T15:56:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/independent-environmental-and-security-monitoring-pbr/attachment/6-gd100-picture-1l/</loc>
		<lastmod>2019-03-29T15:56:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/independent-environmental-and-security-monitoring-pbr/attachment/6-gd100-picture-1l-2/</loc>
		<lastmod>2019-03-29T16:09:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/routewatch-vehicle-security-fleet-management-pbr/attachment/14-trailer-1-to-3-temp-zone-monitoring/</loc>
		<lastmod>2019-03-29T16:15:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/trailer-security-and-inventory-management-pbr/attachment/12-global-compliance/</loc>
		<lastmod>2019-03-29T16:19:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/trailer-security-and-inventory-management-pbr/attachment/8-gd100-specsheet/</loc>
		<lastmod>2019-03-29T16:23:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-recommends-approval-of-revlimid-and-imnovid-based-triplet-combo-regimens-for-multiple-myeloma/attachment/800px-plasmacytoma_ultramini1/</loc>
		<lastmod>2019-04-01T08:54:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-icd-therapeutics/attachment/boengher-2/</loc>
		<lastmod>2019-04-01T09:07:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-tudorza-pressair-snda-to-include-data-for-reduction-of-copd-exacerbations-and-hospitalizations/attachment/tudor/</loc>
		<lastmod>2019-04-01T09:14:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-ipatasertib-breast-cancer-trial/attachment/roche-3/</loc>
		<lastmod>2019-04-01T13:25:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tevas-migraine-treatment-ajovy-receives-eu-approval/attachment/ajovy/</loc>
		<lastmod>2019-04-02T08:05:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/puma-biotechnology-pierre-fabre-enter-into-license-agreement-to-develop-and-commercialize-nerlynx-in-europe/attachment/medic-563423_960_720/</loc>
		<lastmod>2019-04-02T08:10:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-selumetinib/attachment/astra/</loc>
		<lastmod>2019-04-02T08:34:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-acquire-ifm-tre/attachment/tower-with-surrounding-buildings-image-2/</loc>
		<lastmod>2019-04-02T12:09:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sangamo-pfizer-announce-phase-1-2-interim-data-for-investigational-hemophilia-a-gene-therapy/attachment/pfizerworld-7/</loc>
		<lastmod>2019-04-03T08:29:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/que-oncology-launches-phase-2-trials-in-the-us/attachment/wed-cancer-cells-541954_960_720/</loc>
		<lastmod>2019-04-03T08:37:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xencor-astellas-pharma-antibody/attachment/astellas/</loc>
		<lastmod>2019-04-03T09:14:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cellectis-phase-1-trial-ucartcs1/attachment/dna-1903318_960_720/</loc>
		<lastmod>2019-04-03T12:04:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viiv-healthcare-announces-juluca-dolutegravir-rilpivirine-maintains-hiv-viral-suppression-at-148-weeks/attachment/hiv-1903371_960_720/</loc>
		<lastmod>2019-04-04T07:47:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-lung-cancer-vizimpro/attachment/pfizer-3/</loc>
		<lastmod>2019-04-04T09:55:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/capsugel/attachment/capsugel-logo/</loc>
		<lastmod>2019-04-04T15:55:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/twist-bioscience-and-lakepharma-form-strategic-collaboration-to-provide-antibody-discovery-and-development-services/attachment/science-1029385_960_720-2/</loc>
		<lastmod>2019-04-05T08:26:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/puma-biotechnology-expands-cohorts-in-phase-ii-summit-trial-of-neratinib/attachment/tumor-3/</loc>
		<lastmod>2019-04-05T08:31:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/three-pharma-kickback-allegations/attachment/judge/</loc>
		<lastmod>2019-04-05T08:37:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/global-central-laboratory/attachment/logo_barc_rvb_hd/</loc>
		<lastmod>2019-04-05T09:05:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-descovy-hiv-prophylaxis/attachment/hiv-virus/</loc>
		<lastmod>2019-04-08T08:35:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam-sanofi-conclude-research-and-option-phase-of-2014-rnai-therapeutics-collaboration/attachment/sanofi-3/</loc>
		<lastmod>2019-04-08T09:21:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sun-pharma-launches-ready-to-infuse-infugem-in-the-us/attachment/sun-pharma-corporate/</loc>
		<lastmod>2019-04-08T09:36:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celltrion-iprogen-adcs-partnership/attachment/monday-test-214186_960_720/</loc>
		<lastmod>2019-04-08T12:04:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viiv-healthcare-hiv-dovato/attachment/dova/</loc>
		<lastmod>2019-04-09T07:54:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/otitopic-pursues-additional-new-indication-for-dry-powder-inhalation-of-aspirin-as-treatment-for-nsclc/attachment/headache-1540220_960_720/</loc>
		<lastmod>2019-04-09T08:53:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam-regeneron-collaboration-to-discover-develop-and-commercialize-rnai-therapeutics/attachment/neuron/</loc>
		<lastmod>2019-04-09T09:18:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-evenity-osteoporosis/attachment/amgenhead-2/</loc>
		<lastmod>2019-04-10T06:30:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nanology-enrolls-first-patient-in-phase-1-2-clinical-trial-of-nanodoce-to-treat-bladder-cancer/attachment/cancer-2/</loc>
		<lastmod>2019-04-10T08:02:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/poxel-reports-positive-top-line-results-for-imeglimin-phase-3-trial-in-japan/attachment/wed-science-1029385_960_720/</loc>
		<lastmod>2019-04-10T09:26:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/pharmabide-pharmaceutical-services/attachment/pharmabide-lead/</loc>
		<lastmod>2019-04-11T09:50:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/pharmabide-pharmaceutical-services/attachment/logo-273-300x100/</loc>
		<lastmod>2019-04-11T09:52:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-symtuza-diamond-trial/attachment/hiv-1903373_960_720/</loc>
		<lastmod>2019-04-12T06:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/moleculin-announces-agreement-with-emory-university-to-conduct-pediatric-brain-tumor-trial/attachment/chemistry-1-1162205/</loc>
		<lastmod>2019-04-12T10:45:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/askbio-aav-gene-therapy-news/attachment/dna-163466_960_720/</loc>
		<lastmod>2019-04-14T12:41:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/balversa-metastatic-bladder-cancer-fda/attachment/fda_bldg_51_-_main_entrance_5161374834/</loc>
		<lastmod>2019-04-15T06:09:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/what-does-poort-quality-cost/attachment/nsf-pb-white-paper-what-does-poor-quality-cost/</loc>
		<lastmod>2019-04-15T09:26:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr-reddys-laboratories-announces-acquisition-of-anda-portfolio/attachment/dr-_reddys_finished_dosage_facility_iii-2/</loc>
		<lastmod>2019-04-15T10:21:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/catalent-paragon-bioservices/attachment/cdmo/</loc>
		<lastmod>2019-04-16T06:48:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam-initiates-illuminate-b-phase-3-pediatric-study-of-lumasiran-to-treat-primary-hyperoxaluria-type-1/attachment/kidney-2/</loc>
		<lastmod>2019-04-16T08:36:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allele-scm-lifescience-sign-joint-research-and-development-agreement-to-develop-ipsc-based-diabetes-treatment/attachment/diabetes-2058045_960_720/</loc>
		<lastmod>2019-04-16T08:54:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-bla-brolucizumab-wet-amd/attachment/tower-with-surrounding-buildings-image-3/</loc>
		<lastmod>2019-04-16T11:34:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-insitro-steatohepatitis/attachment/liverdisease-2/</loc>
		<lastmod>2019-04-17T07:09:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ms-pharma-genepharm/attachment/ms-pharma-factory-turkey/</loc>
		<lastmod>2019-04-17T10:25:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-neoimmunetechs-hyleukin-7-for-idiopathic-cd4-lymphocytopenia-treatment/attachment/fdadrug-13/</loc>
		<lastmod>2019-04-17T11:18:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dndi-atomwise-collaborate-to-advance-drug-development-using-ai-for-neglected-diseases/attachment/medicalpill/</loc>
		<lastmod>2019-04-17T11:25:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/labcorp-envigo-covance/attachment/labcorp/</loc>
		<lastmod>2019-04-18T07:34:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sk-twoxar-nsclc/attachment/nslsc/</loc>
		<lastmod>2019-04-18T10:55:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-duaklir-pressair-to-treat-chronic-obstructive-pulmonary-disease/attachment/fdadrug-14/</loc>
		<lastmod>2019-04-18T10:58:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/casi-pharmaceuticals-in-licenses-rights-to-novel-anti-cd38-monoclonal-antibody-program-from-black-belt-therapeutics/attachment/malignancy/</loc>
		<lastmod>2019-04-18T11:07:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-lillys-painkiller-tanezumab/attachment/pfizer-4/</loc>
		<lastmod>2019-04-22T07:40:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aqvida-phyton-receive-approval-from-edqm-for-aqvidas-paclitaxel-injectable-fdf/attachment/cancer-cells-541954_960_720-2/</loc>
		<lastmod>2019-04-22T09:23:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viela-bio-receives-us-fda-breakthrough-therapy-designation-for-inebilizumab-to-treat-neuromyelitis-optica-spectrum-disorder/attachment/usfdadevice/</loc>
		<lastmod>2019-04-22T11:28:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-keytruda-pinlyta-renal/attachment/keytruda-100mg-4ml-vial-and-carton-3/</loc>
		<lastmod>2019-04-23T05:43:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forbius-announces-first-patient-dosed-in-phase-2a-egfr-overexpressing-tnbc-trial-of-avid100/attachment/virus-7/</loc>
		<lastmod>2019-04-23T09:47:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-launches-generic-version-of-vesicare-solifenacin-succinate-tablets-in-us/attachment/1280px-tevacanada2/</loc>
		<lastmod>2019-04-23T10:43:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lillys-taltz-phase-3-nr-axspa-trial/attachment/lilly-headquarters/</loc>
		<lastmod>2019-04-23T16:09:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fulcrum-drug-losmapimod-gsk/attachment/pharmadrug/</loc>
		<lastmod>2019-04-24T06:28:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fsd-pharma-to-acquire-prismic-pharmaceuticals/attachment/fsd/</loc>
		<lastmod>2019-04-24T08:10:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/capsugel/attachment/cds-capsules-1/</loc>
		<lastmod>2019-04-24T10:58:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/capsugel-vcaps-plus-capsules/attachment/capsugel-ps-1/</loc>
		<lastmod>2019-04-24T11:12:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/capsugel-colorista/attachment/capsugel-ps-2/</loc>
		<lastmod>2019-04-24T12:24:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/vcaps-enteric-capsules/attachment/capsugel-products-vcaps-enteric/</loc>
		<lastmod>2019-04-24T12:34:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-enforce-program-fremanezumab/attachment/800px-tevacanada2/</loc>
		<lastmod>2019-04-24T16:38:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-vaccine-manufacturing-hamilton/attachment/gsk-house-3/</loc>
		<lastmod>2019-04-25T07:28:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/knopp-biosciences-gets-fda-orphan-drug-designation-for-dexpramipexole-tp-treat-hypereosinophilic-syndrome/attachment/fdadrug-15/</loc>
		<lastmod>2019-04-25T08:07:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kite-announces-plans-for-new-state-of-the-art-facility-to-expand-cell-therapy-production-capabilities/attachment/dna-1903318_960_720-2/</loc>
		<lastmod>2019-04-25T08:19:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aptorum-launches-smart-pharma/attachment/mc_121818118/</loc>
		<lastmod>2019-04-25T09:24:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-selonsertib-nash-study/attachment/liver-5/</loc>
		<lastmod>2019-04-26T07:19:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-pharmaceuticals-usa-recalls-losartan-potassium-25mg-and-100mg-tablets-usp-sold-exclusively-to-golden-state-medical-supply/attachment/tablet-6/</loc>
		<lastmod>2019-04-26T08:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-benlysta-pediatric-lupus/attachment/gsk-head/</loc>
		<lastmod>2019-04-29T07:34:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/navidea-announces-comparative-study-to-evaluate-tilmanocept-in-patients-with-tb/attachment/test-214186_960_720-2/</loc>
		<lastmod>2019-04-29T08:14:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-receives-positive-chmp-opinion-for-talzenna-for-patients-with-inherited-brca-mutated-locally-advanced-or-metastatic-breast-cancer/attachment/pfizer-5/</loc>
		<lastmod>2019-04-29T10:20:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/luspatercept-maa-application/attachment/red-blood-cells-3188223_960_720/</loc>
		<lastmod>2019-04-29T12:47:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viiv-healthcare-cabotegravir-rilpivirine/attachment/hiv-2/</loc>
		<lastmod>2019-04-30T05:50:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/finch-therapeutics-receives-fast-track-designation-for-investigation-of-full-spectrum-microbiota-as-treatment-for-children-with-autism-spectrum-disorder/attachment/fdadrug-16/</loc>
		<lastmod>2019-04-30T09:52:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iktos-janssens-small-molecule/attachment/artificial-intelligence-3382507_960_720/</loc>
		<lastmod>2019-04-30T12:05:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-research-facility-san-diego/attachment/sandiego/</loc>
		<lastmod>2019-05-01T07:26:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sandoz-enters-agreement-for-proposed-trastuzumab-biosimilar-to-treat-selected-her2-positive-cancer-tumors/attachment/tumor-4/</loc>
		<lastmod>2019-05-01T08:20:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-research-facility-san-diego/attachment/sandiego_1600x900_b/</loc>
		<lastmod>2019-05-01T08:29:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sandoz-resubmits-biosimilar-pegfilgrastim-application-to-us-fda/attachment/fdadrug-12/</loc>
		<lastmod>2019-05-01T10:32:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-benevolentai-partnership/attachment/astrazenecabenevolentai/</loc>
		<lastmod>2019-05-01T11:13:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-dengvaxia-vaccine/attachment/mosquito-2/</loc>
		<lastmod>2019-05-02T06:24:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tmunity-uc-san-francisco-collaborate-to-advance-tcr-t-cell-therapies-for-pediatric-cancers/attachment/uccancer/</loc>
		<lastmod>2019-05-02T07:55:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/exelixis-initiates-phase-3-trial-of-cabozantinib-in-advanced-renal-cell-carcinoma/attachment/cancer-cells-541954_960_720-3/</loc>
		<lastmod>2019-05-02T08:36:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-innoviva-trelegy-ellipta/attachment/gsk-3/</loc>
		<lastmod>2019-05-03T07:23:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-syapse-enter-precision-medicine-collaboration-in-oncology/attachment/amgenhead-3/</loc>
		<lastmod>2019-05-03T07:59:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wuxi-apptec-pharmapace-clinical-research/attachment/wuxi-2/</loc>
		<lastmod>2019-05-06T07:29:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qternmet-xr-approved-in-us-for-treatment-of-type-2-diabetes/attachment/astratab-2/</loc>
		<lastmod>2019-05-06T08:57:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-kadcyla-fda-approval/attachment/rochebasel-1-2/</loc>
		<lastmod>2019-05-06T09:25:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pear-therapeutics-initiates-feasibility-study-to-treat-depressive-symptoms-in-people-with-multiple-sclerosis/attachment/test-tubes-2-1494463/</loc>
		<lastmod>2019-05-06T09:36:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lundbeck-acquire-abide-therapeutics/attachment/headquarters_4/</loc>
		<lastmod>2019-05-06T12:02:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-vyndaqel-vyndamax-cardiomyopathy/attachment/pfizernewyork/</loc>
		<lastmod>2019-05-07T07:12:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/deals/ligand-acquires-milestone-and-royalty-rights-to-sb206-from-novan/attachment/handshake-3298455_960_720/</loc>
		<lastmod>2019-05-07T09:38:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xencor-xmab23104-phase-1/attachment/mitosis-3876669_960_720-2/</loc>
		<lastmod>2019-05-07T10:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmacyte-biotech-advances-manufacturing-process-for-clinical-trial-in-pancreatic-cancer/attachment/mitosis/</loc>
		<lastmod>2019-05-07T10:25:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-blood-cancer-calquence/attachment/tabletastra/</loc>
		<lastmod>2019-05-08T07:04:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-belsomra-c-iv-meets-primary-efficacy-endpoint-in-phase-3-trial/attachment/brain-2546101_640/</loc>
		<lastmod>2019-05-08T10:06:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/european-commission-approves-lorviqu-for-certain-adult-patients-with-previously-treated-alk-positive-nsclc/attachment/pfizerworld-8/</loc>
		<lastmod>2019-05-08T11:19:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/7psolutions-climate-control/whitepapers/gd100-tracker/attachment/brochure-to-link-to/</loc>
		<lastmod>2019-05-08T11:23:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-takeda-xiidra/attachment/novartis/</loc>
		<lastmod>2019-05-09T07:06:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-acquires-clinical-stage-biotech-therachon/attachment/pfizerworld-9/</loc>
		<lastmod>2019-05-09T11:35:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-opdivo-brain-cancer/attachment/bms-2/</loc>
		<lastmod>2019-05-09T13:41:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-announces-results-from-phase-2-trial-of-v114-in-infants/attachment/image-2/</loc>
		<lastmod>2019-05-10T02:52:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/magenta-therapeutics-presents-updated-phase-2-clinical-data-on-mgta-456-cell-therapy/attachment/document-3271743_640/</loc>
		<lastmod>2019-05-10T10:40:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spectrum-announces-asset-purchase-and-license-for-immuno-oncology-platform/attachment/business-3141342_1920/</loc>
		<lastmod>2019-05-10T10:52:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vifor-pharma-veltassa-ckd/attachment/sony-dsc/</loc>
		<lastmod>2019-05-13T08:18:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-opens-new-biologics-clinical-manufacturing-facility-in-massachusetts/attachment/pfizerworld-10/</loc>
		<lastmod>2019-05-13T09:37:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sunovion-sep-363856-fda-breakthrough/attachment/1024px-fda_bldg_51_-_main_entrance_5161374834/</loc>
		<lastmod>2019-05-13T16:07:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celgene-pomalyst-kaposi-sarcoma/attachment/pomalyst/</loc>
		<lastmod>2019-05-14T06:24:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lillys-cyramza-becomes-first-fda-approved-biomarker-driven-therapy-in-patients-with-hepatocellular-carcinoma/attachment/lilly/</loc>
		<lastmod>2019-05-14T08:49:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/pfanstiehl/attachment/logo-100/</loc>
		<lastmod>2019-05-14T09:08:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/pfanstiehl/attachment/pfansteihl-lead-image/</loc>
		<lastmod>2019-05-14T09:08:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/galactose-nad/attachment/galactose/</loc>
		<lastmod>2019-05-14T09:17:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/mannitol/attachment/mannitol/</loc>
		<lastmod>2019-05-14T09:20:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/exelixis-collaborator-daiichi-sankyo-launches-minnebro-esaxerenone-tablets-in-japan/attachment/tablets-3-1562059/</loc>
		<lastmod>2019-05-14T09:21:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/sucrose/attachment/sucrose-ld/</loc>
		<lastmod>2019-05-14T09:22:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/trehalose/attachment/trehalose/</loc>
		<lastmod>2019-05-14T09:23:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/pfanstiehl/whitepapers/closing-characterisation-gap-between-api-and-formulation-components/attachment/fd33cace-d6e7-414a-82b6-30157def08f0/</loc>
		<lastmod>2019-05-14T09:26:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/pfanstiehl/whitepapers/trehalose-a-powerful-excipient-in-the-formulation-toolbox/attachment/fb2270c4-1ba3-4b51-b412-21ada22d47fa/</loc>
		<lastmod>2019-05-14T09:29:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/pfanstiehl/whitepapers/narrowing-the-gap-between-active-ingredients-and-critical-excipients/attachment/89459b83-9474-48be-b472-285dd3398dc3/</loc>
		<lastmod>2019-05-14T09:30:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/pfanstiehl/whitepapers/validated-metal-analysis-of-injectable-grade-platform-excipients/attachment/f429f399-70e1-46cc-9080-c74cb20cdf88/</loc>
		<lastmod>2019-05-14T09:33:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elevatebio-biotechnology-holding-company/attachment/basecamp_1/</loc>
		<lastmod>2019-05-14T12:01:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zymeworks-enters-its-first-zymelink-antibody-drug-conjugate-platform-licensing-agreement-with-iconic-therapeutics/attachment/cancer-3/</loc>
		<lastmod>2019-05-15T09:08:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allegro-announces-positive-results-of-ex-us-proof-of-concept-trial-with-alg-1007-for-dry-eye-disease/attachment/her-eye-1502144/</loc>
		<lastmod>2019-05-15T10:23:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/meliors-tolimidone-phase2b-trial/attachment/wed-test-214185_960_720/</loc>
		<lastmod>2019-05-15T11:49:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-leukemia-venclexta-gazyva/attachment/roche-basel/</loc>
		<lastmod>2019-05-16T06:43:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-frazier-healthcare-collaborate-to-launch-phathom-pharmaceuticals/attachment/takeda-2/</loc>
		<lastmod>2019-05-16T08:04:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/stelis-biosource/attachment/stelis_biosource_logo/</loc>
		<lastmod>2019-05-16T10:15:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/stelis-biosource/attachment/stelis-lead/</loc>
		<lastmod>2019-05-16T10:15:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-merck-bavencio-inlyta/attachment/pfizerhq-2/</loc>
		<lastmod>2019-05-16T10:58:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fragmin-fda-approval-vte-pediatrics/attachment/pfizerworldheadquartersentrance-3/</loc>
		<lastmod>2019-05-17T06:25:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/essa-pharma-to-acquire-realm-therapeutics/attachment/writing-1149962_640/</loc>
		<lastmod>2019-05-17T09:29:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/capsugel-vcaps-plus-capsules/attachment/vcaps-plus-gold/</loc>
		<lastmod>2019-05-17T11:07:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/capsugel-colorista/attachment/colorista/</loc>
		<lastmod>2019-05-17T11:11:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/vcaps-enteric-capsules/attachment/vcaps-enteric/</loc>
		<lastmod>2019-05-17T11:13:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvie-glioblastoma-trial-depatux-m/attachment/abbvie_depatux-m_phase-3-trial/</loc>
		<lastmod>2019-05-20T07:44:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ligand-licenses-ver250840-to-cumulus-oncology/attachment/cancer-cells-541954_960_720-4/</loc>
		<lastmod>2019-05-20T11:02:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-fda-approves-gattex-for-children-above-one-year-of-age-with-short-bowel-syndrome/attachment/20may-pharma/</loc>
		<lastmod>2019-05-20T11:12:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/catalent-acquires-cdmo-paragon/attachment/dna-163466_960_720-2/</loc>
		<lastmod>2019-05-21T06:39:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/cbdepot/attachment/cpdepot-cannabidiol-1l/</loc>
		<lastmod>2019-05-21T08:21:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/cbdepot/attachment/cbdepot-logo/</loc>
		<lastmod>2019-05-21T08:27:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/springworks-therapeutics-initiates-phase-3-trial-of-nirogacestat-in-desmoid-tumors/attachment/stethoscope-2617701_640/</loc>
		<lastmod>2019-05-21T11:09:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/springworks-therapeutics-initiates-phase-3-trial-of-nirogacestat-in-desmoid-tumors/attachment/cancer-cells-541954_960_720-5/</loc>
		<lastmod>2019-05-21T11:34:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-peloton-therapeutics/attachment/therapeutic-2/</loc>
		<lastmod>2019-05-22T06:30:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wuxi-biologics-signed-letter-of-intent-for-long-term-vaccine-manufacturing-contract/attachment/syringe/</loc>
		<lastmod>2019-05-22T08:54:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wasdell-build-new-facility-ireland/attachment/17oca1/</loc>
		<lastmod>2019-05-22T13:30:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-nuevolution/attachment/amgenhead-4/</loc>
		<lastmod>2019-05-23T06:53:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-sorilux-for-adolescent-plaque-psoriasis/attachment/fdadrug-17/</loc>
		<lastmod>2019-05-23T10:07:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cyclica-launches-new-multi-targeted-drug-design-technology-ligand-design/attachment/thu-laboratory-3827745_960_720/</loc>
		<lastmod>2019-05-23T11:05:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-qvm149-phase-2-asthma/attachment/tower-with-logo-through-branches-image/</loc>
		<lastmod>2019-05-23T11:52:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-shingles-vaccine-shingrix/attachment/gsk-4/</loc>
		<lastmod>2019-05-24T04:51:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucsf-doses-first-patient-in-triple-combination-clinical-trial-of-oncosecs-tavo-epacadostat-and-keytruda/attachment/bacteria-2/</loc>
		<lastmod>2019-05-24T08:42:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/upmarket-cannabinoid-ingredients/attachment/cannabis-enriched-ps-1/</loc>
		<lastmod>2019-05-24T09:31:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/trans-cannabidiol/attachment/ps-2-cannabidiol_cbd/</loc>
		<lastmod>2019-05-24T10:09:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/cannabigerol/attachment/ps-2-cannabigerol_cbd/</loc>
		<lastmod>2019-05-24T10:17:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nektar-therapeutics-launches-inheris-biopharma/attachment/nek-laboratory-3827745_960_720/</loc>
		<lastmod>2019-05-24T10:24:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/hemp-flavouring-preparations/attachment/ps-3-hemp-flavouring/</loc>
		<lastmod>2019-05-24T10:38:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chiesi-santheras-raxone-rights/attachment/business-3141342_960_720/</loc>
		<lastmod>2019-05-25T06:23:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-breast-piqray-fulvestrant/attachment/novar/</loc>
		<lastmod>2019-05-27T07:07:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/knopp-reports-positive-preclinical-data-for-neonatal-epilepsy-drug-candidate/attachment/epilepsy-623346_960_720/</loc>
		<lastmod>2019-05-27T10:45:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-gene-therapy-to-treat-pediatric-patients-with-spinal-muscular-atrophy/attachment/fdadrug-18/</loc>
		<lastmod>2019-05-27T11:01:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lyrica-phase-3-trial-pgtc-seizures/attachment/pfizerworldheadquartersentrance-4/</loc>
		<lastmod>2019-05-27T12:02:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neuraxpharm-probiotic-europe/attachment/neuro/</loc>
		<lastmod>2019-05-28T08:01:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-reaches-agreement-with-oklahoma-to-resolve-states-claims/attachment/1280px-tevacanada2-2/</loc>
		<lastmod>2019-05-28T10:54:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/last-patient-enrolls-in-phase-2-trial-with-transgenes-tg4010-nivolumab-chemotherapy-for-first-line-treatment-of-advanced-nsclc/attachment/mitosis-2/</loc>
		<lastmod>2019-05-28T11:35:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/santhera-idebenone-dmd-ema/attachment/european_commision-001_-_brussel/</loc>
		<lastmod>2019-05-28T12:22:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celgene-revlimid-rituximab/attachment/blood-cancer/</loc>
		<lastmod>2019-05-29T07:42:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/autoject2-platform/attachment/ps3lead/</loc>
		<lastmod>2019-05-29T08:04:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/autoject-micro-platform/attachment/ps1/</loc>
		<lastmod>2019-05-29T08:06:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/autoject-mini-platform/attachment/ps2lead/</loc>
		<lastmod>2019-05-29T08:09:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/autopen1-platform/attachment/ps4lead/</loc>
		<lastmod>2019-05-29T08:11:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/autopen2-platform/attachment/ps5lead/</loc>
		<lastmod>2019-05-29T08:13:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/unisafe/attachment/ps6lead/</loc>
		<lastmod>2019-05-29T08:16:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/owen-mumford-pbr-storefront/whitepapers/anapen2a-is-the-next-generation-of-anaphylaxis-auto-injectors/attachment/dc0c780c-4296-4711-a507-1c7747f82ae9/</loc>
		<lastmod>2019-05-29T08:20:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/owen-mumford-pbr-storefront/whitepapers/autoject-micro/attachment/60eb7dc0-7663-41d5-b1e1-bdb6f89a9d93/</loc>
		<lastmod>2019-05-29T08:22:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/owen-mumford-pbr-storefront/whitepapers/passive-safety-device-for-pre-fillable-syringes/attachment/db1dddc2-6158-4aaa-88bb-bbbce3837670/</loc>
		<lastmod>2019-05-29T08:24:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viela-bio-collaborates-with-hansoh-pharma-to-develop-and-commercialize-inebilizumab-for-autoimmune-diseases-and-hematologic-cancers-in-china/attachment/autovirus/</loc>
		<lastmod>2019-05-29T09:21:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/juvenescence-launches-souvien-therapeutics-to-address-neurodegenerative-diseases/attachment/high-street-agreement-3489902_960_720/</loc>
		<lastmod>2019-05-29T11:05:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-centrexion-cntx-0290/attachment/1024px-2006_0219firstfujifolder0012/</loc>
		<lastmod>2019-05-29T12:03:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merz-xeomin-chronic-sialorrhea/attachment/merz/</loc>
		<lastmod>2019-05-30T07:42:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-phase-iii-quartz-study-of-new-investigational-inhaled-combination-treatment-meets-primary-and-key-secondary-endpoints/attachment/epta/</loc>
		<lastmod>2019-05-30T09:34:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-phase-iii-quartz-study-of-new-investigational-inhaled-combination-treatment-meets-primary-and-key-secondary-endpoints/attachment/novar-2/</loc>
		<lastmod>2019-05-30T09:34:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-gubra-to-develop-anti-obesity-peptide-poly-agonists/attachment/800px-siedziba_boehringer_ingelheim_w_polsce/</loc>
		<lastmod>2019-05-30T10:32:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/contractors/vetter_pharma_international/news/vetter-works-towards-sustainable-energy-supply/attachment/vetter-works-towards-a-sustainable-energy-supply/</loc>
		<lastmod>2019-05-30T13:33:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lantheus-nanomab-immuno-oncology/attachment/virus-8/</loc>
		<lastmod>2019-05-31T07:06:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lantheus-nanomab-immuno-oncology/attachment/virus-1812092_1280/</loc>
		<lastmod>2019-05-31T07:24:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epizyme-submits-nda-to-us-fda-for-tazemetostat-to-treat-epithelioid-sarcoma/attachment/fdadrug-19/</loc>
		<lastmod>2019-05-31T08:52:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex-to-submit-vx-445-tezacaftor-and-ivacaftor-regimen-for-global-regulatory-approvals-in-cystic-fibrosis/attachment/1024px-clubbingcf/</loc>
		<lastmod>2019-05-31T10:47:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentechs-xolair-chronic-rhinosinusitis/attachment/archivnummer-4076-2/</loc>
		<lastmod>2019-06-03T07:54:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imfinzi-is-only-immunotherapy-to-demonstrate-overall-survival-at-three-years-in-unresectable-stage-iii-non-small-cell-lung-cancer/attachment/tabastra/</loc>
		<lastmod>2019-06-03T10:49:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kite-humanigen-to-evaluate-yescarta-lenzilumab-combo-in-relapsed-refractory-dlbcl/attachment/cancer-cells-541954_960_720-6/</loc>
		<lastmod>2019-06-03T11:06:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kisqali-breast-cancer-phase-3-trial/attachment/kisqali-product-and-packaging-2/</loc>
		<lastmod>2019-06-03T11:46:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-dupixent-for-moderate-to-severe-atopic-dermatitis-in-adolescents/attachment/fdadrug-9/</loc>
		<lastmod>2019-06-04T10:50:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-approves-zynteglo-ttd/attachment/blood-1813410_960_720/</loc>
		<lastmod>2019-06-04T11:30:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/pfanstiehl/whitepapers/pfanstiehl-excipients-high-purity-low-endotoxin-and-low-metal/attachment/2019-high-purity-low-endotoxin-low-metals-critical-excipients/</loc>
		<lastmod>2019-06-05T11:29:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/willy-a-bachofen-ag-maschinenfabrik/attachment/wab_neu1/</loc>
		<lastmod>2019-06-05T14:44:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/glass-ampoules/attachment/schott-ampoules-ps-2-2/</loc>
		<lastmod>2019-06-05T15:29:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/glass-ampoules/attachment/brochure_schott_ampoules_row/</loc>
		<lastmod>2019-06-05T15:45:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/prefillable-polymer-syringes/attachment/x-20140521165320031/</loc>
		<lastmod>2019-06-05T15:50:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/schott-prefillable-syringes-pharmaceutical-packaging/attachment/x-20140521165043984/</loc>
		<lastmod>2019-06-05T15:53:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/schott-prefillable-syringes-pharmaceutical-packaging/attachment/brochure-schott-syriq_row/</loc>
		<lastmod>2019-06-05T15:56:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eli-lilly-emgality-headache/attachment/eli-lilly/</loc>
		<lastmod>2019-06-06T07:58:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/reata-pharmaceuticals-gets-orphan-drug-designation-for-bardoxolone-methyl-to-treat-adpkd/attachment/fdadrug-21/</loc>
		<lastmod>2019-06-06T09:00:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cstone-secures-approval-in-china-for-clinical-trial-of-cs1001-blu-554-combo-for-hcc/attachment/cancer-cells-541954_960_720-7/</loc>
		<lastmod>2019-06-06T10:22:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/venetoclax-obinutuzumab-cll-phase-3/attachment/roche-location-3/</loc>
		<lastmod>2019-06-06T11:05:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/schott-vials-pharmaceutical-packaging/attachment/schott-vials/</loc>
		<lastmod>2019-06-06T14:16:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/schott-vials-pharmaceutical-packaging/attachment/schott-brochure-schott-vials-english-20092017/</loc>
		<lastmod>2019-06-06T14:19:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/prefillable-polymer-syringes/attachment/brochure-schott-toppac_row/</loc>
		<lastmod>2019-06-06T14:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/schott-pharma-services/attachment/brochure_sps_row/</loc>
		<lastmod>2019-06-06T14:27:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/schott-pharma-services/attachment/schott/</loc>
		<lastmod>2019-06-06T14:31:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/current-innovations-glass-pharmaceutical-packaging/attachment/schottcurrent/</loc>
		<lastmod>2019-06-06T14:35:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/glass-cartridges/attachment/brochure_schott_cartridges_row-2/</loc>
		<lastmod>2019-06-06T15:26:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/goldfinch-bio-initiates-phase-1-clinical-trial-of-gfb-887-for-kidney-disease/attachment/goldfinch-science-1029385_960_720/</loc>
		<lastmod>2019-06-07T06:54:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex-exonics-therapeutics/attachment/vertex/</loc>
		<lastmod>2019-06-07T07:10:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-presents-first-of-its-kind-histology-data-with-iscalimab/attachment/novartis-2/</loc>
		<lastmod>2019-06-07T08:01:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/calquence-phase-3-cll-trial/attachment/astrazeneca-hq-9/</loc>
		<lastmod>2019-06-07T11:43:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acucela-emixustat-stargardt-disease/attachment/human-eye-3/</loc>
		<lastmod>2019-06-10T07:42:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/protokinetix-achieves-primary-objective-safety-at-midpoint-of-clinical-trial/attachment/diabetes-2/</loc>
		<lastmod>2019-06-10T08:49:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/contract-immune-monitoring-and-research/whitepapers/detection-of-antigen-specific-t-cell-lineages-and-effector-functions/attachment/detection-of-antigenspecific-t-cell-lineages-and-effector-functions-based-on-secretory-signature/</loc>
		<lastmod>2019-06-10T09:31:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/contract-immune-monitoring-and-research/whitepapers/detecting-clonally-expanded-stem-cell-like-melanoma-antigen-specific-cd8-memory-cells/attachment/przybyla2019_article_naturaltcellautoreactivitytome/</loc>
		<lastmod>2019-06-10T09:36:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nference-enters-into-rd-data-science-partnership-with-janssen/attachment/artificial-intelligence-3382507_960_720-2/</loc>
		<lastmod>2019-06-10T10:59:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/theramex-bijuva-imvexxy-therapeuticsmd/attachment/theramex-business-3167295_960_720/</loc>
		<lastmod>2019-06-10T11:38:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/gerresheimer/attachment/gerresheimer-lead/</loc>
		<lastmod>2019-06-10T13:55:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/gerresheimer/attachment/logo-5-2/</loc>
		<lastmod>2019-06-10T13:57:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-tilos-therapeutics/attachment/tilo/</loc>
		<lastmod>2019-06-11T07:10:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aptar-acquires-nanopharm-and-gateway-analytical-to-accelerate-customer-drug-development/attachment/aptar/</loc>
		<lastmod>2019-06-11T08:06:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-polivy-brcombo-dlbcl-fda/attachment/genetech-0081967/</loc>
		<lastmod>2019-06-11T12:59:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/debiopharm-ipsen-extend-strategic-decapeptyl-partnership-for-another-15-years/attachment/decap/</loc>
		<lastmod>2019-06-12T08:22:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-psoriatic-arthritis/attachment/novar-3/</loc>
		<lastmod>2019-06-12T08:32:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/ampoules/attachment/main-9/</loc>
		<lastmod>2019-06-12T09:08:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/pharmaceutical-bottles/attachment/main-200/</loc>
		<lastmod>2019-06-12T09:13:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/cartridges/attachment/main-249/</loc>
		<lastmod>2019-06-12T09:18:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/syringe-systems/attachment/main-79/</loc>
		<lastmod>2019-06-12T09:22:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/vials/attachment/main-139/</loc>
		<lastmod>2019-06-12T09:27:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/gerresheimer/whitepapers/correlations-between-viscosity-needle-diameter-flow-rate-and-dose-accuracy/attachment/2019_sensile_medical_-converted/</loc>
		<lastmod>2019-06-12T09:31:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/gerresheimer/whitepapers/pharmaceutical-primary-packaging-made-of-glass/attachment/1d925f4a-ba17-4ac3-8ccb-8708cdceeef7/</loc>
		<lastmod>2019-06-12T09:33:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/gerresheimer/whitepapers/medical-plastic-systems/attachment/c7d200ff-ece6-4fd1-aec7-c833f90cc1be/</loc>
		<lastmod>2019-06-12T09:35:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/gerresheimer/attachment/logo-5-3/</loc>
		<lastmod>2019-06-12T09:38:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/gerresheimer/attachment/logo-5-4/</loc>
		<lastmod>2019-06-12T09:39:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-university-of-dundee-extend-anti-cancer-alliance/attachment/800px-siedziba_boehringer_ingelheim_w_polsce-2/</loc>
		<lastmod>2019-06-12T11:00:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dassault-medidata-solutions/attachment/dassaluit/</loc>
		<lastmod>2019-06-13T07:42:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/bea-technologies/attachment/bea-technologies-logo/</loc>
		<lastmod>2019-06-13T09:05:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/bea-technologies/attachment/bea-technologies-lead/</loc>
		<lastmod>2019-06-13T09:06:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vernalis-phoremost-announce-drug-discovery-collaboration-for-novel-oncology-target/attachment/oncology-3/</loc>
		<lastmod>2019-06-13T11:09:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-announces-results-from-xeljanz-xr-oral-shift-study/attachment/pfizer-6/</loc>
		<lastmod>2019-06-13T11:17:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-rastuzumab-kanjinti/attachment/amgenheadquat/</loc>
		<lastmod>2019-06-14T07:25:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/corvidia-therapeutics-initiates-phase-2b-dose-finding-study-for-ziltivekimab/attachment/kidney-3/</loc>
		<lastmod>2019-06-14T10:49:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/dyno-mill-pharma/attachment/csm_wab-group_agitator_bead_mill_dyno-mill_ml-cip-sip_14ee548445/</loc>
		<lastmod>2019-06-14T11:10:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/dyno-mill-ecm-ap-05/attachment/csm_wab-group_agitator_bead_mill_dyno-mill_ecm-ap05_91f105d8e6/</loc>
		<lastmod>2019-06-14T12:43:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/products/turbula/attachment/csm_wab-group_3d_shaker_mixer_turbula_t2f_foodgrade_3a8180938e/</loc>
		<lastmod>2019-06-14T12:47:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-lokelma-esrd-trial/attachment/tabletastra-2/</loc>
		<lastmod>2019-06-17T07:56:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr-reddys-to-sell-neurology-branded-products-to-upsher-smith-laboratories/attachment/reddys/</loc>
		<lastmod>2019-06-17T09:36:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion-reports-positive-phase-3-extension-data-for-ultomiris-in-paroxysmal-nocturnal-hemoglobinuria/attachment/alex-test-214185_960_720/</loc>
		<lastmod>2019-06-17T10:49:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-array-biopharma/attachment/pfizer-7/</loc>
		<lastmod>2019-06-18T07:23:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ose-doses-first-patient-in-phase-1-trial-of-sirp%ce%b1-antagonist-monoclonal-antibody/attachment/boengher-3/</loc>
		<lastmod>2019-06-18T09:14:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/sanofi-cepia-pbr/whitepapers/sanofi-active-ingredient-solutions-product-list/attachment/sanofi_sais_produtc-list-2019_gb/</loc>
		<lastmod>2019-06-18T10:49:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mycovia-jiangsu-hengrui-to-develop-and-commercialize-antifungal-therapy-vt-1161/attachment/china-laboratory-3827745_960_720/</loc>
		<lastmod>2019-06-18T10:50:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-lynparza-ovarian/attachment/lyparenza/</loc>
		<lastmod>2019-06-19T06:51:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-gets-japanese-approval-for-personalised-medicine-rozlytrek/attachment/roche-4/</loc>
		<lastmod>2019-06-19T08:53:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/victoza-fda-paediatric-approval/attachment/novo-nordisk-headquarters/</loc>
		<lastmod>2019-06-19T10:15:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rocket-begins-patient-dosing-in-phase-1-trial-of-rp-a501-in-danon-disease/attachment/dna-163466_960_720-3/</loc>
		<lastmod>2019-06-19T10:51:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/linaclotide-phase-3b-trial-ibs-c/attachment/linaclotide-science-1029385_960_720/</loc>
		<lastmod>2019-06-19T12:08:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-nurix-treatments-cancer/attachment/gilead/</loc>
		<lastmod>2019-06-20T06:41:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gamida-cell-lonza-establish-commercial-manufacturing-agreement-for-omidubicel/attachment/bloodmarrow/</loc>
		<lastmod>2019-06-20T08:09:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ribomic-announces-positive-top-line-results-from-phase-1-2a-trial-of-rbm-007-in-wet-amd/attachment/ribomictest-214185_960_720/</loc>
		<lastmod>2019-06-20T11:00:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion-ultomiris-ahus/attachment/fdadrug-23/</loc>
		<lastmod>2019-06-21T07:02:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/horizon-therapeutics-initiates-mirror-trial-evaluating-krystexxa-in-combination-with-methotrexate/attachment/tabletgout/</loc>
		<lastmod>2019-06-21T09:45:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-announces-collaboration-with-us-universities-to-expand-data-science-research-in-healthcare/attachment/monitor-1307227_960_720/</loc>
		<lastmod>2019-06-21T10:24:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-breast-cancer-talzenna/attachment/pfizer-8/</loc>
		<lastmod>2019-06-24T07:59:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam-announces-progress-with-rnai-therapeutics-platform/attachment/oral/</loc>
		<lastmod>2019-06-24T10:49:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/botox-fda-paediatric-approval-uls/attachment/1024px-allergan_headquarters/</loc>
		<lastmod>2019-06-24T12:16:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/differentiation-of-thc-and-cbd-cannabis-using-ftir5/attachment/an_m157_differentiation_of_cannabis_ftir/</loc>
		<lastmod>2019-06-24T13:48:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-celgene-psoriasis-otezla/attachment/bristol/</loc>
		<lastmod>2019-06-25T07:01:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-carna-biosciences-collaborate-to-develop-novel-immuno-oncology-therapies/attachment/gilead-2/</loc>
		<lastmod>2019-06-25T09:00:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nantkwest-launches-phase-1-trial-with-targeted-pd-l1-t-hank-cell-therapy-in-patients-with-solid-tumors/attachment/cancer-cells-541954_960_720-8/</loc>
		<lastmod>2019-06-25T11:10:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tesaro-niraparib-fda-priority-review/attachment/fda_bldg_51_-_main_entrance_5161374834-2/</loc>
		<lastmod>2019-06-25T11:48:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rafael-pharmaceuticals-ono-pharmaceutical-to-accelerate-clinical-development-of-cancer-drug-candidate-cpi-613/attachment/ono/</loc>
		<lastmod>2019-06-26T10:26:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imbrium-initiates-phase-2-study-of-imb-115-in-insomnia-associated-with-alcohol-cessation/attachment/test-tubes-1-1494460/</loc>
		<lastmod>2019-06-26T10:29:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tilt-123-avelumab-combo-trial/attachment/tilt-mitosis-3876669_960_720/</loc>
		<lastmod>2019-06-26T11:36:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regeneron-sanofi-dupixent-nasal/attachment/fdadrug-24/</loc>
		<lastmod>2019-06-27T06:52:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-to-empagliflozin-to-treat-chronic-heart-failure/attachment/chronic-heart/</loc>
		<lastmod>2019-06-27T08:31:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acceleron-completes-target-enrollment-in-phase-2-trial-of-sotatercept-in-pah/attachment/heart-2222964_960_720/</loc>
		<lastmod>2019-06-27T11:34:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion-soliris-nmosd/attachment/alextablet/</loc>
		<lastmod>2019-06-28T07:15:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lung-cancer-drug-imfinzi-improves-overall-survival-at-interim-analysis-in-the-phase-iii-caspian-trial/attachment/drug-8/</loc>
		<lastmod>2019-06-28T10:32:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xeris-doses-first-patient-in-phase-2-trial-of-developmental-ready-to-use-glucagon-in-pbh/attachment/ct-science-1029385_960_720/</loc>
		<lastmod>2019-06-28T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-avastin-biosimilar-zirabev/attachment/pfizer-9/</loc>
		<lastmod>2019-07-01T08:20:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/how-to-get-more-training-budget-in-a-world-of-scarcity/attachment/nsf-ph-white-paper-how-to-get-more-training-budget-in-a-world-of-scarcity/</loc>
		<lastmod>2019-07-01T10:20:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-recommends-eu-approval-of-roches-tecentriq-plus-abraxane-for-metastatic-tnbc/attachment/roche-5/</loc>
		<lastmod>2019-07-01T10:24:35+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->